RESTful Lookup — Test-Drive (2007 – 2026)

Query complete (40 ms elapsed)

{
  "NDC": [
    {
      "NDCCode": "50114-6141-5",
      "PackageDescription": "15 TABLET in 1 BOTTLE (50114-6141-5)",
      "NDC11Code": "50114-6141-05",
      "ProductNDC": "50114-6141",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Coenzyme Compositum",
      "NonProprietaryName": "Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20030831",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "BETA VULGARIS; ASCORBIC ACID; CYSTEINE; MAGNESIUM OROTATE; MANGANESE PHOSPHATE, DIBASIC; SODIUM DIETHYL OXALACETATE; NIACINAMIDE; PULSATILLA VULGARIS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; .ALPHA.-LIPOIC ACID; .ALPHA.-KETOGLUTARIC ACID; CEROUS OXALATE NONAHYDRATE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COENZYME A; FUMARIC ACID; MALIC ACID; NADIDE; SODIUM PYRUVATE; SUCCINIC ACID; ADENOSINE TRIPHOSPHATE; BARIUM OXALOSUCCINATE; CALCIUM SULFIDE; SULFUR",
      "StrengthNumber": "4; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 10; 10; 10; 10",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2019-01-08",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231"
    },
    {
      "NDCCode": "0268-6141-06",
      "PackageDescription": "5 mL in 1 VIAL, MULTI-DOSE (0268-6141-06) ",
      "NDC11Code": "00268-6141-06",
      "ProductNDC": "0268-6141",
      "ProductTypeName": "NON-STANDARDIZED ALLERGENIC",
      "ProprietaryName": "Grapefruit",
      "NonProprietaryName": "Citrus X Paradisi",
      "DosageFormName": "INJECTION, SOLUTION",
      "RouteName": "PERCUTANEOUS",
      "StartMarketingDate": "19650101",
      "MarketingCategoryName": "BLA",
      "ApplicationNumber": "BLA103753",
      "LabelerName": "ALK-Abello, Inc.",
      "SubstanceName": "GRAPEFRUIT",
      "StrengthNumber": ".1",
      "StrengthUnit": "g/mL",
      "Pharm_Classes": "Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]",
      "Status": "Active",
      "LastUpdate": "2025-08-11",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "19650101",
      "SamplePackage": "N",
      "IndicationAndUsage": "These products are for diagnostic use only. Diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. By measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. For extracts standardized in AU and BAU, see individual directions for use. Allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use.",
      "Description": "Sterile diagnostic extracts are supplied in either phenol-saline diluent for Intradermal Testing or in diluent containing glycerin 50% (v/v) for Percutaneous Testing and phenol 0.4% (preservative). Inactive ingredients may include: sodium chloride for isotonicity, glycerin, and sodium bicarbonate as a buffer. Pollens are individually extracted from pure pollen extracted in a phenol-preserved sodium bicarbonate solution. Short Ragweed and Mixed (Tall and Short) Ragweed extracts are standardized by Antigen E content and so labeled. The Antigen E content of extracts containing Short Ragweed at a concentration more dilute than a weight/volume ratio of 1:10 are obtained by calculating the Antigen E content based on the assay value of more concentrated extract. Pollen extracts are filtered aseptically and after final packaging, they are tested for sterility and safety. Molds are individwually extracted from pure powdered inactivated mold source material extracted in phenol preserved saline. Mold extracts are filtered aseptically and after final packaging are tested for sterility and safety. Molds (fungi) are present in all inhabited places at all seasons of the year; they are so ubiquitous that they are prevalent at times when common allergic pollens and other inhalants are not. In the home and surroundings, molds are found in upholstered furniture, mattresses, drapes, cellar and storage room dust, woolens, leather goods, fruits, meats, cheeses, garden soil and on plants. Spores, mycelial fragments and mold residues are thus inhaled, contacted and ingested continuously. Foods, miscellaneous inhalants and epidermals are individually extracted in phenol preserved saline or glycerin, filtered aseptically and after final packaging are tested for sterility and safety."
    },
    {
      "NDCCode": "50114-6141-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-6141-2)",
      "NDC11Code": "50114-6141-02",
      "ProductNDC": "50114-6141",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Coenzyme Compositum",
      "NonProprietaryName": "Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20030831",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "BETA VULGARIS; ASCORBIC ACID; CYSTEINE; MAGNESIUM OROTATE; MANGANESE PHOSPHATE, DIBASIC; SODIUM DIETHYL OXALACETATE; NIACINAMIDE; PULSATILLA VULGARIS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; .ALPHA.-LIPOIC ACID; .ALPHA.-KETOGLUTARIC ACID; CEROUS OXALATE NONAHYDRATE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COENZYME A; FUMARIC ACID; MALIC ACID; NADIDE; SODIUM PYRUVATE; SUCCINIC ACID; ADENOSINE TRIPHOSPHATE; BARIUM OXALOSUCCINATE; CALCIUM SULFIDE; SULFUR",
      "StrengthNumber": "4; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 10; 10; 10; 10",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2019-01-08",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231"
    },
    {
      "NDCCode": "50114-1350-5",
      "PackageDescription": "15 TABLET in 1 BOTTLE (50114-1350-5)",
      "NDC11Code": "50114-1350-05",
      "ProductNDC": "50114-1350",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Neurexan",
      "NonProprietaryName": "Avena Sativa Flowering Top, Passiflora Incarnata Top, Zinc Valerate Dihydrate And Arabica Coffee Bean",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20110705",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; PASSIFLORA INCARNATA TOP; ZINC VALERATE DIHYDRATE",
      "StrengthNumber": "12; 2; 2; 4",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-6065-5",
      "PackageDescription": "15 BOTTLE in 1 BOTTLE (50114-6065-5)  > 100 TABLET in 1 BOTTLE (50114-6065-2)",
      "NDC11Code": "50114-6065-05",
      "ProductNDC": "50114-6065",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Engystol",
      "NonProprietaryName": "Cynanchum Vincetoxicum Root And Sulfur",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20130610",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "CYNANCHUM VINCETOXICUM ROOT; SULFUR",
      "StrengthNumber": "6; 4",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-6150-5",
      "PackageDescription": "15 TABLET in 1 BLISTER PACK (50114-6150-5)",
      "NDC11Code": "50114-6150-05",
      "ProductNDC": "50114-6150",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Traumeel",
      "NonProprietaryName": "Aconitum Napellus, Arnica Montana Root, Atropa Belladonna, Bellis Perennis, Calendula Officinalis Flowering Top, Chamomile, Echinacea, Unspecified, Echinacea Purpurea, Hamamelis Virginiana Root Bark/stem Bark, Calcium Sulfide, Hypericum Perforatum, Mercurius Solubilis, Achillea Millefolium And Comfrey Root",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "19840131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; CHAMOMILE; ECHINACEA, UNSPECIFIED; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; CALCIUM SULFIDE; HYPERICUM PERFORATUM; MERCURIUS SOLUBILIS; ACHILLEA MILLEFOLIUM; COMFREY ROOT",
      "StrengthNumber": "3; 3; 4; 2; 2; 3; 2; 2; 2; 8; 3; 8; 3; 8",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2017-08-08"
    },
    {
      "NDCCode": "50114-6169-5",
      "PackageDescription": "15 TABLET in 1 BOTTLE (50114-6169-5)",
      "NDC11Code": "50114-6169-05",
      "ProductNDC": "50114-6169",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Adrisin",
      "NonProprietaryName": "Antimony Trisulfide, Arnica Montana Root, Arsenic Trioxide, Formic Acid, Graphite, Histamine Dihydrochloride, Strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Selenium, Sulfur, Sulfuric Acid, Tellurium And Thuja Occidentalis Leafy Twig",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20100301",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARNICA MONTANA ROOT; ARSENIC TRIOXIDE; FORMIC ACID; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; PINE TAR; SELENIUM; STRYCHNOS IGNATII SEED; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG",
      "StrengthNumber": "10; 8; 6; 8; 8; 10; 8; 8; 6; 10; 12; 6; 12; 22; 10; 6",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "0463-6141-05",
      "PackageDescription": "500 TABLET in 1 BOTTLE, PLASTIC (0463-6141-05)",
      "NDC11Code": "00463-6141-05",
      "ProductNDC": "0463-6141",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Prednisone",
      "NonProprietaryName": "Prednisone",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20030213",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA087342",
      "LabelerName": "C.O. Truxton, Inc.",
      "SubstanceName": "PREDNISONE",
      "StrengthNumber": "20",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2019-09-21",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Prednisone tablets and solutions are indicated in the following conditions.",
      "Description": "Each tablet for oral administration contains. Prednisone.............................................................1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, and 50 mg. Each 5 mL of oral solution for oral administration contains. Prednisone............................................................................................................................... 5 mg. Alcohol.................................................................................................................................... 5%. Each mL of Intensol for oral administration contains. Prednisone............................................................................................................................... 5 mg. Alcohol.................................................................................................................................... 30%."
    },
    {
      "NDCCode": "0641-6141-10",
      "PackageDescription": "10 VIAL in 1 CARTON (0641-6141-10)  > 10 mL in 1 VIAL (0641-6141-01)",
      "NDC11Code": "00641-6141-10",
      "ProductNDC": "0641-6141",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Neostigmine Methylsulfate",
      "NonProprietaryName": "Neostigmine Methylsulfate",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
      "StartMarketingDate": "19730101",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "West-ward Pharmaceutical Corp.",
      "SubstanceName": "NEOSTIGMINE METHYLSULFATE",
      "StrengthNumber": ".5",
      "StrengthUnit": "mg/mL",
      "Pharm_Classes": "Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2017-07-11"
    },
    {
      "NDCCode": "54868-6141-0",
      "PackageDescription": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6141-0)",
      "NDC11Code": "54868-6141-00",
      "ProductNDC": "54868-6141",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Venlafaxine Hydrochloride",
      "NonProprietaryName": "Venlafaxine Hydrochloride",
      "DosageFormName": "CAPSULE, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20101108",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA076565",
      "LabelerName": "Physicians Total Care, Inc.",
      "SubstanceName": "VENLAFAXINE HYDROCHLORIDE",
      "StrengthNumber": "37.5",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2018-07-24",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8 and 12 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III-R or DSM-IV category of major depressive disorder (see Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The efficacy of venlafaxine hydrochloride tablets (immediate release) in the treatment of major depressive disorder in adult inpatients meeting diagnostic criteria for major depressive disorder with melancholia was established in a 4 week controlled trial (see Clinical Trials). The safety and efficacy of venlafaxine hydrochloride extended-release capsules in hospitalized depressed patients have not been adequately studied. The efficacy of venlafaxine hydrochloride extended-release capsules in maintaining a response in major depressive disorder for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial. The efficacy of venlafaxine hydrochloride tablets (immediate release) in maintaining a response in patients with recurrent major depressive disorder who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo-controlled trial (see Clinical Trials). Nevertheless, the physician who elects to use venlafaxine hydrochloride tablets/venlafaxine hydrochloride extended-release capsules for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).",
      "Description": "Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride. The structural formula is shown below. C17H27NO2HCl M.W. 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43. Venlafaxine hydrochloride extended-release capsules are formulated as an extended-release capsule for once-a-day oral administration. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of black iron oxide, dibutyl sebacate, ethylcellulose, gelatin, polyethylene glycol, povidone, propylene glycol, shellac, sugar spheres (which contain sucrose and corn starch), sunset yellow FCF FD&C yellow 6, talc, and titanium dioxide. The 37.5 mg capsules also contain D&C yellow 10 and potassium hydroxide, the 75 mg capsules also contain D&C yellow 10 and may contain potassium hydroxide, and the 150 mg capsules also contain potassium hydroxide."
    },
    {
      "NDCCode": "54868-6141-1",
      "PackageDescription": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6141-1)",
      "NDC11Code": "54868-6141-01",
      "ProductNDC": "54868-6141",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Venlafaxine Hydrochloride",
      "NonProprietaryName": "Venlafaxine Hydrochloride",
      "DosageFormName": "CAPSULE, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20101108",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA076565",
      "LabelerName": "Physicians Total Care, Inc.",
      "SubstanceName": "VENLAFAXINE HYDROCHLORIDE",
      "StrengthNumber": "37.5",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2018-07-24",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8 and 12 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III-R or DSM-IV category of major depressive disorder (see Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The efficacy of venlafaxine hydrochloride tablets (immediate release) in the treatment of major depressive disorder in adult inpatients meeting diagnostic criteria for major depressive disorder with melancholia was established in a 4 week controlled trial (see Clinical Trials). The safety and efficacy of venlafaxine hydrochloride extended-release capsules in hospitalized depressed patients have not been adequately studied. The efficacy of venlafaxine hydrochloride extended-release capsules in maintaining a response in major depressive disorder for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial. The efficacy of venlafaxine hydrochloride tablets (immediate release) in maintaining a response in patients with recurrent major depressive disorder who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo-controlled trial (see Clinical Trials). Nevertheless, the physician who elects to use venlafaxine hydrochloride tablets/venlafaxine hydrochloride extended-release capsules for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).",
      "Description": "Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride. The structural formula is shown below. C17H27NO2HCl M.W. 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43. Venlafaxine hydrochloride extended-release capsules are formulated as an extended-release capsule for once-a-day oral administration. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of black iron oxide, dibutyl sebacate, ethylcellulose, gelatin, polyethylene glycol, povidone, propylene glycol, shellac, sugar spheres (which contain sucrose and corn starch), sunset yellow FCF FD&C yellow 6, talc, and titanium dioxide. The 37.5 mg capsules also contain D&C yellow 10 and potassium hydroxide, the 75 mg capsules also contain D&C yellow 10 and may contain potassium hydroxide, and the 150 mg capsules also contain potassium hydroxide."
    },
    {
      "NDCCode": "54868-6141-2",
      "PackageDescription": "180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6141-2)",
      "NDC11Code": "54868-6141-02",
      "ProductNDC": "54868-6141",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Venlafaxine Hydrochloride",
      "NonProprietaryName": "Venlafaxine Hydrochloride",
      "DosageFormName": "CAPSULE, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20101108",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA076565",
      "LabelerName": "Physicians Total Care, Inc.",
      "SubstanceName": "VENLAFAXINE HYDROCHLORIDE",
      "StrengthNumber": "37.5",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2018-07-24",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8 and 12 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III-R or DSM-IV category of major depressive disorder (see Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The efficacy of venlafaxine hydrochloride tablets (immediate release) in the treatment of major depressive disorder in adult inpatients meeting diagnostic criteria for major depressive disorder with melancholia was established in a 4 week controlled trial (see Clinical Trials). The safety and efficacy of venlafaxine hydrochloride extended-release capsules in hospitalized depressed patients have not been adequately studied. The efficacy of venlafaxine hydrochloride extended-release capsules in maintaining a response in major depressive disorder for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial. The efficacy of venlafaxine hydrochloride tablets (immediate release) in maintaining a response in patients with recurrent major depressive disorder who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo-controlled trial (see Clinical Trials). Nevertheless, the physician who elects to use venlafaxine hydrochloride tablets/venlafaxine hydrochloride extended-release capsules for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).",
      "Description": "Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride. The structural formula is shown below. C17H27NO2HCl M.W. 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43. Venlafaxine hydrochloride extended-release capsules are formulated as an extended-release capsule for once-a-day oral administration. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of black iron oxide, dibutyl sebacate, ethylcellulose, gelatin, polyethylene glycol, povidone, propylene glycol, shellac, sugar spheres (which contain sucrose and corn starch), sunset yellow FCF FD&C yellow 6, talc, and titanium dioxide. The 37.5 mg capsules also contain D&C yellow 10 and potassium hydroxide, the 75 mg capsules also contain D&C yellow 10 and may contain potassium hydroxide, and the 150 mg capsules also contain potassium hydroxide."
    },
    {
      "NDCCode": "50114-0113-6",
      "PackageDescription": "10 AMPULE in 1 CARTON (50114-0113-6)  > 2.2 mL in 1 AMPULE",
      "NDC11Code": "50114-0113-06",
      "ProductNDC": "50114-0113",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Echinacea Compositum Forte",
      "NonProprietaryName": "Aconitum Napellus,echinacea, Unspecified, Arnica Montana Root, Baptisia Tinctoria Root ,toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Bryonia Alba Root, Eupatorium Perfoliatum Flowering Top, Euphorbia Resinifera Resin, Gelsemium Sempervirens Root, Phytolacca Americana Root, Silver Nitrate, Arsenic Trioxide, Mercuric Chloride, Phosphorus, Pulsatilla Vulgaris, Sulfur,thuja Occidentalis Leafy Twig,calcium Sulfide,lachesis Muta Venom,",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "19930131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS; LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS PYOGENES; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC",
      "StrengthNumber": "5; 6; 10; 6; 8; 12; 15; 3; 8; 8; 8; 15; 12; 8; 10; 8; 10; 6; 10; 20; 20; 20; 20; 10; 10; 6; 12",
      "StrengthUnit": "[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL",
      "Pharm_Classes": "Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-22"
    },
    {
      "NDCCode": "50114-0114-2",
      "PackageDescription": "10 VIAL, SINGLE-DOSE in 1 CARTON (50114-0114-2)  > .45 mL in 1 VIAL, SINGLE-DOSE",
      "NDC11Code": "50114-0114-02",
      "ProductNDC": "50114-0114",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Oculoheel",
      "NonProprietaryName": "Cochlearia Officinalis Flowering Top,echinacea Angustifolia,euphrasia Stricta And Pilocarpus Jaborandi Leaf",
      "DosageFormName": "SOLUTION/ DROPS",
      "RouteName": "INTRAOCULAR",
      "StartMarketingDate": "20050627",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "COCHLEARIA OFFICINALIS FLOWERING TOP; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; PILOCARPUS JABORANDI LEAF",
      "StrengthNumber": "5; 5; 5; 5",
      "StrengthUnit": "[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL",
      "Status": "Deprecated",
      "LastUpdate": "2017-01-30"
    },
    {
      "NDCCode": "50114-0119-2",
      "PackageDescription": "15 VIAL, SINGLE-DOSE in 1 CARTON (50114-0119-2)  > .45 mL in 1 VIAL, SINGLE-DOSE",
      "NDC11Code": "50114-0119-02",
      "ProductNDC": "50114-0119",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Clearlife",
      "NonProprietaryName": "Cochlearia Officinalis Flowering Top, Echinacea, Unspecified, Euphrasia Stricta And Pilocarpus Jaborandi Leaf",
      "DosageFormName": "SOLUTION/ DROPS",
      "RouteName": "OPHTHALMIC",
      "StartMarketingDate": "20130404",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "COCHLEARIA OFFICINALIS FLOWERING TOP; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; PILOCARPUS JABORANDI LEAF",
      "StrengthNumber": "5; 5; 5; 5",
      "StrengthUnit": "[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-0227-2",
      "PackageDescription": "30000 mg in 1 BOTTLE (50114-0227-2)",
      "NDC11Code": "50114-0227-02",
      "ProductNDC": "50114-0227",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Atropinum Compositum Rx",
      "NonProprietaryName": "Atropine Sulfate And Bryonia Alba Root And Arsenic Trioxide And Berberis Vulgaris Root Bark And Citrullus Colocynthis Fruit Pulp And Cupric Acetate And Chondrodendron Tomentosum Root And Veratrum Album Root And Baptisia Tinctoria Root And Chelidonium Majus And Lytta Vesicatoria And Gonorrheal Urethral Secretion Human And Clematis Recta Flowering Top And Thuja Occidentalis Leafy Twig And Benzoic Acid And Silver Nitrate",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20030830",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ATROPINE SULFATE; BRYONIA ALBA ROOT; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; CHONDRODENDRON TOMENTOSUM ROOT; VERATRUM ALBUM ROOT; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS; LYTTA VESICATORIA; GONORRHEAL URETHRAL SECRETION HUMAN; CLEMATIS RECTA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; BENZOIC ACID; SILVER NITRATE",
      "StrengthNumber": "4; 1; 4; 1; 1; 2; 1; 1; 1; 1; 5; 10; 1; 1; 2; 1",
      "StrengthUnit": "[hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg",
      "Pharm_Classes": "Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC]",
      "Status": "Deprecated",
      "LastUpdate": "2017-04-04"
    },
    {
      "NDCCode": "50114-1122-6",
      "PackageDescription": "10 AMPULE in 1 CARTON (50114-1122-6)  > 1.1 mL in 1 AMPULE",
      "NDC11Code": "50114-1122-06",
      "ProductNDC": "50114-1122",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Vertigoheel",
      "NonProprietaryName": "Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Ambergris, Kerosene",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "19930131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; AMBERGRIS; KEROSENE",
      "StrengthNumber": "3; 2; 5; 7",
      "StrengthUnit": "[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL",
      "Status": "Deprecated",
      "LastUpdate": "2017-01-30"
    },
    {
      "NDCCode": "50114-1164-6",
      "PackageDescription": "10 AMPULE in 1 CARTON (50114-1164-6)  > 2.2 mL in 1 AMPULE",
      "NDC11Code": "50114-1164-06",
      "ProductNDC": "50114-1164",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Thalamus Compositum",
      "NonProprietaryName": "Adenosine Cyclic Phosphate, Sus Scrofa Pineal Gland, Sus Scrofa Thalamus Lateral Geniculate Nucleus, Sus Scrofa Adrenal Gland And Viscum Album Fruiting Top",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "19930131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; VISCUM ALBUM FRUITING TOP",
      "StrengthNumber": "6; 5; 8; 8; 10",
      "StrengthUnit": "[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; 1/2.2mL",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-22"
    },
    {
      "NDCCode": "50114-2324-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-2324-2)",
      "NDC11Code": "50114-2324-02",
      "ProductNDC": "50114-2324",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Bhi Arthritis",
      "NonProprietaryName": "Antimony Potassium Tartrate, Atropa Belladonna , Blatta Orientalis, Bryonia Alba Whole, Anemone Americana, Star Anise, Ipecac, Lobelia Inflata, Naphthalene, Sodium Sulfate, Aspidosperma Quebracho-blanco Bark, And Stachys Officinalis",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20000930",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BLATTA ORIENTALIS; BRYONIA ALBA WHOLE; ANEMONE AMERICANA; STAR ANISE; IPECAC; LOBELIA INFLATA; NAPHTHALENE; SODIUM SULFATE; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; STACHYS OFFICINALIS",
      "StrengthNumber": "6; 6; 8; 8; 5; 6; 4; 5; 6; 6; 6; 4",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2017-04-04"
    },
    {
      "NDCCode": "50114-3201-4",
      "PackageDescription": "50 mL in 1 BOTTLE (50114-3201-4)",
      "NDC11Code": "50114-3201-04",
      "ProductNDC": "50114-3201",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Lymphomyosot Oral Drop",
      "NonProprietaryName": "Araneus Diadematus, Tribasic Calcium Phosphate, Equisetum Hyemale, Ferrous Iodide, Fumaria Officinalis Flowering Top,gentiana Lutea Root, Geranium Robertianum, Levothyroxine, Myosotis Arvensis, Sodium Sulfide Nonahydrate, Nasturtium Officinale, Pinus Sylvestris Leafy Twig, Smilax Regelii Root, Scrophularia Nodosa,teucrium Scorodonia Flowering Top, And Veronica Officinalis Flowering Top",
      "DosageFormName": "LIQUID",
      "RouteName": "ORAL",
      "StartMarketingDate": "20071231",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; LEVOTHYROXINE; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX REGELII ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP",
      "StrengthNumber": "6; 4; 12; 4; 5; 4; 12; 3; 4; 4; 3; 6; 4; 3; 12; 3",
      "StrengthUnit": "[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-3205-4",
      "PackageDescription": "50 mL in 1 BOTTLE (50114-3205-4)",
      "NDC11Code": "50114-3205-04",
      "ProductNDC": "50114-3205",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Naso-heel",
      "NonProprietaryName": "Goldenseal And Lobaria Pulmonaria And Potassium Dichromate And Phosphorus And Mercuric Sulfide And Ammonium Carbonate And Lemna Minor And Arum Maculatum Root And Mercuric Iodide",
      "DosageFormName": "LIQUID",
      "RouteName": "ORAL",
      "StartMarketingDate": "19860131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "GOLDENSEAL; LOBARIA PULMONARIA; POTASSIUM DICHROMATE; PHOSPHORUS; MERCURIC SULFIDE; AMMONIUM CARBONATE; LEMNA MINOR; ARUM MACULATUM ROOT; MERCURIC IODIDE",
      "StrengthNumber": "4; 4; 5; 6; 8; 3; 3; 4; 8",
      "StrengthUnit": "[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL",
      "Status": "Deprecated",
      "LastUpdate": "2017-02-20"
    },
    {
      "NDCCode": "50114-4262-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-4262-2)",
      "NDC11Code": "50114-4262-02",
      "ProductNDC": "50114-4262",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Back",
      "NonProprietaryName": "Citrullus Colocynthis Fruit Pulp And Pseudognaphalium Obtusifolium And Ammonium Chloride And Gelsemium Sempervirens Root And Toxicodendron Pubescens Leaf And Arsenic Trioxide And Matricaria Recutita And",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20070830",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "CITRULLUS COLOCYNTHIS FRUIT PULP; PSEUDOGNAPHALIUM OBTUSIFOLIUM; AMMONIUM CHLORIDE; GELSEMIUM SEMPERVIRENS ROOT; TOXICODENDRON PUBESCENS LEAF; ARSENIC TRIOXIDE; MATRICARIA RECUTITA",
      "StrengthNumber": "5; 5; 6; 6; 8; 10; 10",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2018-04-09",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231"
    },
    {
      "NDCCode": "50114-4263-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-4263-2)",
      "NDC11Code": "50114-4263-02",
      "ProductNDC": "50114-4263",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Bhi Back",
      "NonProprietaryName": "Ammonium Chloride, Matricaria Recutita, Citrullus Colocynthis Fruit Pulp, Gelsemium Sempervirens Root, Pseudognaphalium Obtusifolium And Toxicodendron Pubescens Leaf",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20070830",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "AMMONIUM CHLORIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA RECUTITA; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF",
      "StrengthNumber": "6; 5; 6; 10; 8; 8",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-4290-2",
      "PackageDescription": "30000 mg in 1 BOTTLE (50114-4290-2)",
      "NDC11Code": "50114-4290-02",
      "ProductNDC": "50114-4290",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Arthritis",
      "NonProprietaryName": "Bryonia Alba Root And Toxicodendron Pubescens Leaf And Citrullus Colocynthis Fruit Pulp And Arnica Montana Root And Colchicum Autumnale Bulb And Solanum Dulcamara Top And Ledum Palustre Twig And Ranunculus Bulbosus And Berberis Vulgaris Root Bark And Causticum And Rhododendron Aureum Leaf And Lycopodium Clavatum Spore And Sulfur And Ferrosoferric Phosphate",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20000930",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; FERROSOFERRIC PHOSPHATE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RANUNCULUS BULBOSUS; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF",
      "StrengthNumber": "6; 8; 4; 8; 5; 6; 12; 6; 10; 6; 8; 6; 10; 4",
      "StrengthUnit": "[hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg",
      "Status": "Deprecated",
      "LastUpdate": "2014-09-12"
    },
    {
      "NDCCode": "50114-4291-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-4291-2)",
      "NDC11Code": "50114-4291-02",
      "ProductNDC": "50114-4291",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Bhi Arthritis",
      "NonProprietaryName": "Arnica Montana Root, Berberis Vulgaris Root Bark , Bryonia Alba Root, Causticum, Citrullus Colocynthis Fruit Pulp, Solanum Dulcamara Top, Ferrosoferric Phosphate, Ledum Palustre Twig, Lycopodium Clavatum Spore, Ranunculus Bulbosus, Rhododendron Aureum Leaf,toxicodendron Pubescens Leaf And Sulfur",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20000930",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; FERROSOFERRIC PHOSPHATE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RANUNCULUS BULBOSUS; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF",
      "StrengthNumber": "6; 8; 4; 8; 5; 12; 6; 10; 6; 8; 6; 10; 4",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-4375-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-4375-2)",
      "NDC11Code": "50114-4375-02",
      "ProductNDC": "50114-4375",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Diarrhea",
      "NonProprietaryName": "Aloe, Arsenic Trioxide, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Mercuric Chloride, Podophyllum, Potentilla Erecta Root And Veratrum Album Root",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "19950131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "ACTIVATED CHARCOAL; ALOE; ARSENIC TRIOXIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; FERROSOFERRIC PHOSPHATE; MERCURIC CHLORIDE; PODOPHYLLUM; POTENTILLA ERECTA ROOT; VERATRUM ALBUM ROOT",
      "StrengthNumber": "12; 4; 6; 6; 6; 10; 6; 6; 4; 5",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-4376-2",
      "PackageDescription": "100 TABLET in 1 BOTTLE (50114-4376-2)",
      "NDC11Code": "50114-4376-02",
      "ProductNDC": "50114-4376",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Diarrhea",
      "NonProprietaryName": "Aloe, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Podophyllum, Potentilla Erecta Root And Veratrum Album Root",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20140601",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc.",
      "SubstanceName": "ACTIVATED CHARCOAL; ALOE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; FERROSOFERRIC PHOSPHATE; PODOPHYLLUM; POTENTILLA ERECTA ROOT; VERATRUM ALBUM ROOT",
      "StrengthNumber": "12; 4; 6; 6; 10; 6; 4; 5",
      "StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-29"
    },
    {
      "NDCCode": "50114-5120-6",
      "PackageDescription": "10 AMPULE in 1 CARTON (50114-5120-6)  > 2.2 mL in 1 AMPULE",
      "NDC11Code": "50114-5120-06",
      "ProductNDC": "50114-5120",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Cactus Compositum",
      "NonProprietaryName": "Crataegus Laevigata Fruit, Selenicereus Grandiflorus Stem, Potassium Dichromate,spigelia Anthelmia, And Nitroglycerin",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "19930131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "CRATAEGUS LAEVIGATA FRUIT; NITROGLYCERIN; POTASSIUM DICHROMATE; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA",
      "StrengthNumber": "2; 5; 5; 3; 5",
      "StrengthUnit": "[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL",
      "Pharm_Classes": "Nitrate Vasodilator [EPC],Nitrates [Chemical/Ingredient],Vasodilation [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-22"
    },
    {
      "NDCCode": "50114-5206-6",
      "PackageDescription": "10 AMPULE in 1 CARTON (50114-5206-6)  > 1.1 mL in 1 AMPULE",
      "NDC11Code": "50114-5206-06",
      "ProductNDC": "50114-5206",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Galium-heel",
      "NonProprietaryName": "Betula Pendula Leaf,caltha Palustris,sedum Acre,thuja Occidentalis Leafy Twig,clematis Recta Flowering Top,hedera Helix Flowering Twig, Juniper Berry, Ononis Spinosa Whole,saponaria Officinalis Root, Sempervivum Tectorum Leaf, Echinacea, Unspecified, Nitric Acid, Rancid Beef, Silver, Calcium Fluoride, Phosphorus,gold, Apis Mellifera, Galium Aparine, Galium Boreale Leaf And Urtica Urens",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "19930131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "APIS MELLIFERA; BETULA PENDULA LEAF; CALCIUM FLUORIDE; CALTHA PALUSTRIS; CLEMATIS RECTA FLOWERING TOP; ECHINACEA, UNSPECIFIED; GALIUM APARINE; GALIUM BOREALE LEAF; GOLD; HEDERA HELIX FLOWERING TWIG; JUNIPER BERRY; NITRIC ACID; ONONIS SPINOSA WHOLE; PHOSPHORUS; RANCID BEEF; SAPONARIA OFFICINALIS ROOT; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS",
      "StrengthNumber": "12; 2; 8; 3; 4; 5; 3; 3; 10; 4; 4; 6; 4; 8; 6; 4; 3; 4; 8; 3; 3",
      "StrengthUnit": "[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL",
      "Pharm_Classes": "Non-Standardized Food Allergenic Extract [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Dietary Proteins [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Food Additives [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Bee Venoms [Chemical/Ingredient],Standardized Insect Venom Allergenic Extract [EPC]",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-22"
    },
    {
      "NDCCode": "50114-5265-6",
      "PackageDescription": "10 AMPULE in 1 CARTON (50114-5265-6)  > 1.1 mL in 1 AMPULE",
      "NDC11Code": "50114-5265-06",
      "ProductNDC": "50114-5265",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Lymphomyosot",
      "NonProprietaryName": "Geranium Robertianum, Nasturtium Officinale, Ferrous Iodide, Juglans Regia Leaf, Juglans Regia Fruit Rind, Immature, Myosotis Arvensis, Scrophularia Nodosa, Teucrium Scorodonia Flowering Top, Veronica Officinalis Flowering Top, Equisetum Hyemale, Fumaria Officinalis Flowering Top, Sodium Sulfate, Pinus Sylvestris Flowering Top,gentiana Lutea Root, Araneus Diadematus, Smilax Regelii Root, Tribasic Calcium Phosphate And Levothyroxine",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "19930131",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Heel Inc",
      "SubstanceName": "ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA LEAF; LEVOTHYROXINE; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS FLOWERING TOP; SCROPHULARIA NODOSA; SMILAX REGELII ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP",
      "StrengthNumber": "6; 4; 12; 4; 5; 4; 3; 12; 3; 4; 4; 3; 6; 4; 3; 12; 3",
      "StrengthUnit": "[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL",
      "Pharm_Classes": "Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient]",
      "Status": "Deprecated",
      "LastUpdate": "2014-08-22"
    }
  ]
}
                    

{"NDC":[{"NDCCode":"50114-6141-5","ProprietaryName":"Coenzyme Compositum","NonProprietaryName":"Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid"},{"NDCCode":"0268-6141-06","ProprietaryName":"Grapefruit","NonProprietaryName":"Citrus X Paradisi"},{"NDCCode":"50114-6141-2","ProprietaryName":"Coenzyme Compositum","NonProprietaryName":"Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid"},{"NDCCode":"50114-1350-5","ProprietaryName":"Neurexan","NonProprietaryName":"Avena Sativa Flowering Top, Passiflora Incarnata Top, Zinc Valerate Dihydrate And Arabica Coffee Bean"},{"NDCCode":"50114-6065-5","ProprietaryName":"Engystol","NonProprietaryName":"Cynanchum Vincetoxicum Root And Sulfur"},{"NDCCode":"50114-6150-5","ProprietaryName":"Traumeel","NonProprietaryName":"Aconitum Napellus, Arnica Montana Root, Atropa Belladonna, Bellis Perennis, Calendula Officinalis Flowering Top, Chamomile, Echinacea, Unspecified, Echinacea Purpurea, Hamamelis Virginiana Root Bark/stem Bark, Calcium Sulfide, Hypericum Perforatum, Mercurius Solubilis, Achillea Millefolium And Comfrey Root"},{"NDCCode":"50114-6169-5","ProprietaryName":"Adrisin","NonProprietaryName":"Antimony Trisulfide, Arnica Montana Root, Arsenic Trioxide, Formic Acid, Graphite, Histamine Dihydrochloride, Strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Selenium, Sulfur, Sulfuric Acid, Tellurium And Thuja Occidentalis Leafy Twig"},{"NDCCode":"0463-6141-05","ProprietaryName":"Prednisone","NonProprietaryName":"Prednisone"},{"NDCCode":"0641-6141-10","ProprietaryName":"Neostigmine Methylsulfate","NonProprietaryName":"Neostigmine Methylsulfate"},{"NDCCode":"54868-6141-0","ProprietaryName":"Venlafaxine Hydrochloride","NonProprietaryName":"Venlafaxine Hydrochloride"},{"NDCCode":"54868-6141-1","ProprietaryName":"Venlafaxine Hydrochloride","NonProprietaryName":"Venlafaxine Hydrochloride"},{"NDCCode":"54868-6141-2","ProprietaryName":"Venlafaxine Hydrochloride","NonProprietaryName":"Venlafaxine Hydrochloride"},{"NDCCode":"50114-0113-6","ProprietaryName":"Echinacea Compositum Forte","NonProprietaryName":"Aconitum Napellus,echinacea, Unspecified, Arnica Montana Root, Baptisia Tinctoria Root ,toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Bryonia Alba Root, Eupatorium Perfoliatum Flowering Top, Euphorbia Resinifera Resin, Gelsemium Sempervirens Root, Phytolacca Americana Root, Silver Nitrate, Arsenic Trioxide, Mercuric Chloride, Phosphorus, Pulsatilla Vulgaris, Sulfur,thuja Occidentalis Leafy Twig,calcium Sulfide,lachesis Muta Venom,"},{"NDCCode":"50114-0114-2","ProprietaryName":"Oculoheel","NonProprietaryName":"Cochlearia Officinalis Flowering Top,echinacea Angustifolia,euphrasia Stricta And Pilocarpus Jaborandi Leaf"},{"NDCCode":"50114-0119-2","ProprietaryName":"Clearlife","NonProprietaryName":"Cochlearia Officinalis Flowering Top, Echinacea, Unspecified, Euphrasia Stricta And Pilocarpus Jaborandi Leaf"},{"NDCCode":"50114-0227-2","ProprietaryName":"Atropinum Compositum Rx","NonProprietaryName":"Atropine Sulfate And Bryonia Alba Root And Arsenic Trioxide And Berberis Vulgaris Root Bark And Citrullus Colocynthis Fruit Pulp And Cupric Acetate And Chondrodendron Tomentosum Root And Veratrum Album Root And Baptisia Tinctoria Root And Chelidonium Majus And Lytta Vesicatoria And Gonorrheal Urethral Secretion Human And Clematis Recta Flowering Top And Thuja Occidentalis Leafy Twig And Benzoic Acid And Silver Nitrate"},{"NDCCode":"50114-1122-6","ProprietaryName":"Vertigoheel","NonProprietaryName":"Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Ambergris, Kerosene"},{"NDCCode":"50114-1164-6","ProprietaryName":"Thalamus Compositum","NonProprietaryName":"Adenosine Cyclic Phosphate, Sus Scrofa Pineal Gland, Sus Scrofa Thalamus Lateral Geniculate Nucleus, Sus Scrofa Adrenal Gland And Viscum Album Fruiting Top"},{"NDCCode":"50114-2324-2","ProprietaryName":"Bhi Arthritis","NonProprietaryName":"Antimony Potassium Tartrate, Atropa Belladonna , Blatta Orientalis, Bryonia Alba Whole, Anemone Americana, Star Anise, Ipecac, Lobelia Inflata, Naphthalene, Sodium Sulfate, Aspidosperma Quebracho-blanco Bark, And Stachys Officinalis"},{"NDCCode":"50114-3201-4","ProprietaryName":"Lymphomyosot Oral Drop","NonProprietaryName":"Araneus Diadematus, Tribasic Calcium Phosphate, Equisetum Hyemale, Ferrous Iodide, Fumaria Officinalis Flowering Top,gentiana Lutea Root, Geranium Robertianum, Levothyroxine, Myosotis Arvensis, Sodium Sulfide Nonahydrate, Nasturtium Officinale, Pinus Sylvestris Leafy Twig, Smilax Regelii Root, Scrophularia Nodosa,teucrium Scorodonia Flowering Top, And Veronica Officinalis Flowering Top"},{"NDCCode":"50114-3205-4","ProprietaryName":"Naso-heel","NonProprietaryName":"Goldenseal And Lobaria Pulmonaria And Potassium Dichromate And Phosphorus And Mercuric Sulfide And Ammonium Carbonate And Lemna Minor And Arum Maculatum Root And Mercuric Iodide"},{"NDCCode":"50114-4262-2","ProprietaryName":"Back","NonProprietaryName":"Citrullus Colocynthis Fruit Pulp And Pseudognaphalium Obtusifolium And Ammonium Chloride And Gelsemium Sempervirens Root And Toxicodendron Pubescens Leaf And Arsenic Trioxide And Matricaria Recutita And"},{"NDCCode":"50114-4263-2","ProprietaryName":"Bhi Back","NonProprietaryName":"Ammonium Chloride, Matricaria Recutita, Citrullus Colocynthis Fruit Pulp, Gelsemium Sempervirens Root, Pseudognaphalium Obtusifolium And Toxicodendron Pubescens Leaf"},{"NDCCode":"50114-4290-2","ProprietaryName":"Arthritis","NonProprietaryName":"Bryonia Alba Root And Toxicodendron Pubescens Leaf And Citrullus Colocynthis Fruit Pulp And Arnica Montana Root And Colchicum Autumnale Bulb And Solanum Dulcamara Top And Ledum Palustre Twig And Ranunculus Bulbosus And Berberis Vulgaris Root Bark And Causticum And Rhododendron Aureum Leaf And Lycopodium Clavatum Spore And Sulfur And Ferrosoferric Phosphate"},{"NDCCode":"50114-4291-2","ProprietaryName":"Bhi Arthritis","NonProprietaryName":"Arnica Montana Root, Berberis Vulgaris Root Bark , Bryonia Alba Root, Causticum, Citrullus Colocynthis Fruit Pulp, Solanum Dulcamara Top, Ferrosoferric Phosphate, Ledum Palustre Twig, Lycopodium Clavatum Spore, Ranunculus Bulbosus, Rhododendron Aureum Leaf,toxicodendron Pubescens Leaf And Sulfur"},{"NDCCode":"50114-4375-2","ProprietaryName":"Diarrhea","NonProprietaryName":"Aloe, Arsenic Trioxide, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Mercuric Chloride, Podophyllum, Potentilla Erecta Root And Veratrum Album Root"},{"NDCCode":"50114-4376-2","ProprietaryName":"Diarrhea","NonProprietaryName":"Aloe, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Podophyllum, Potentilla Erecta Root And Veratrum Album Root"},{"NDCCode":"50114-5120-6","ProprietaryName":"Cactus Compositum","NonProprietaryName":"Crataegus Laevigata Fruit, Selenicereus Grandiflorus Stem, Potassium Dichromate,spigelia Anthelmia, And Nitroglycerin"},{"NDCCode":"50114-5206-6","ProprietaryName":"Galium-heel","NonProprietaryName":"Betula Pendula Leaf,caltha Palustris,sedum Acre,thuja Occidentalis Leafy Twig,clematis Recta Flowering Top,hedera Helix Flowering Twig, Juniper Berry, Ononis Spinosa Whole,saponaria Officinalis Root, Sempervivum Tectorum Leaf, Echinacea, Unspecified, Nitric Acid, Rancid Beef, Silver, Calcium Fluoride, Phosphorus,gold, Apis Mellifera, Galium Aparine, Galium Boreale Leaf And Urtica Urens"},{"NDCCode":"50114-5265-6","ProprietaryName":"Lymphomyosot","NonProprietaryName":"Geranium Robertianum, Nasturtium Officinale, Ferrous Iodide, Juglans Regia Leaf, Juglans Regia Fruit Rind, Immature, Myosotis Arvensis, Scrophularia Nodosa, Teucrium Scorodonia Flowering Top, Veronica Officinalis Flowering Top, Equisetum Hyemale, Fumaria Officinalis Flowering Top, Sodium Sulfate, Pinus Sylvestris Flowering Top,gentiana Lutea Root, Araneus Diadematus, Smilax Regelii Root, Tribasic Calcium Phosphate And Levothyroxine"}]}
                    

<?xml version="1.0" encoding="utf-8"?>
<NDCList>
  <NDC>
    <NDCCode>50114-6141-5</NDCCode>
    <PackageDescription>15 TABLET in 1 BOTTLE (50114-6141-5)</PackageDescription>
    <NDC11Code>50114-6141-05</NDC11Code>
    <ProductNDC>50114-6141</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Coenzyme Compositum</ProprietaryName>
    <NonProprietaryName>Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20030831</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>BETA VULGARIS; ASCORBIC ACID; CYSTEINE; MAGNESIUM OROTATE; MANGANESE PHOSPHATE, DIBASIC; SODIUM DIETHYL OXALACETATE; NIACINAMIDE; PULSATILLA VULGARIS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; .ALPHA.-LIPOIC ACID; .ALPHA.-KETOGLUTARIC ACID; CEROUS OXALATE NONAHYDRATE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COENZYME A; FUMARIC ACID; MALIC ACID; NADIDE; SODIUM PYRUVATE; SUCCINIC ACID; ADENOSINE TRIPHOSPHATE; BARIUM OXALOSUCCINATE; CALCIUM SULFIDE; SULFUR</SubstanceName>
    <StrengthNumber>4; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 10; 10; 10; 10</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2019-01-08</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
  </NDC>
  <NDC>
    <NDCCode>0268-6141-06</NDCCode>
    <PackageDescription>5 mL in 1 VIAL, MULTI-DOSE (0268-6141-06) </PackageDescription>
    <NDC11Code>00268-6141-06</NDC11Code>
    <ProductNDC>0268-6141</ProductNDC>
    <ProductTypeName>NON-STANDARDIZED ALLERGENIC</ProductTypeName>
    <ProprietaryName>Grapefruit</ProprietaryName>
    <NonProprietaryName>Citrus X Paradisi</NonProprietaryName>
    <DosageFormName>INJECTION, SOLUTION</DosageFormName>
    <RouteName>PERCUTANEOUS</RouteName>
    <StartMarketingDate>19650101</StartMarketingDate>
    <MarketingCategoryName>BLA</MarketingCategoryName>
    <ApplicationNumber>BLA103753</ApplicationNumber>
    <LabelerName>ALK-Abello, Inc.</LabelerName>
    <SubstanceName>GRAPEFRUIT</SubstanceName>
    <StrengthNumber>.1</StrengthNumber>
    <StrengthUnit>g/mL</StrengthUnit>
    <Pharm_Classes>Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]</Pharm_Classes>
    <Status>Active</Status>
    <LastUpdate>2025-08-11</LastUpdate>
    <PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
    <ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
    <StartMarketingDatePackage>19650101</StartMarketingDatePackage>
    <SamplePackage>N</SamplePackage>
    <IndicationAndUsage>These products are for diagnostic use only. Diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. By measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. For extracts standardized in AU and BAU, see individual directions for use. Allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use.</IndicationAndUsage>
    <Description>Sterile diagnostic extracts are supplied in either phenol-saline diluent for Intradermal Testing or in diluent containing glycerin 50% (v/v) for Percutaneous Testing and phenol 0.4% (preservative). Inactive ingredients may include: sodium chloride for isotonicity, glycerin, and sodium bicarbonate as a buffer. Pollens are individually extracted from pure pollen extracted in a phenol-preserved sodium bicarbonate solution. Short Ragweed and Mixed (Tall and Short) Ragweed extracts are standardized by Antigen E content and so labeled. The Antigen E content of extracts containing Short Ragweed at a concentration more dilute than a weight/volume ratio of 1:10 are obtained by calculating the Antigen E content based on the assay value of more concentrated extract. Pollen extracts are filtered aseptically and after final packaging, they are tested for sterility and safety. Molds are individwually extracted from pure powdered inactivated mold source material extracted in phenol preserved saline. Mold extracts are filtered aseptically and after final packaging are tested for sterility and safety. Molds (fungi) are present in all inhabited places at all seasons of the year; they are so ubiquitous that they are prevalent at times when common allergic pollens and other inhalants are not. In the home and surroundings, molds are found in upholstered furniture, mattresses, drapes, cellar and storage room dust, woolens, leather goods, fruits, meats, cheeses, garden soil and on plants. Spores, mycelial fragments and mold residues are thus inhaled, contacted and ingested continuously. Foods, miscellaneous inhalants and epidermals are individually extracted in phenol preserved saline or glycerin, filtered aseptically and after final packaging are tested for sterility and safety.</Description>
  </NDC>
  <NDC>
    <NDCCode>50114-6141-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-6141-2)</PackageDescription>
    <NDC11Code>50114-6141-02</NDC11Code>
    <ProductNDC>50114-6141</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Coenzyme Compositum</ProprietaryName>
    <NonProprietaryName>Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20030831</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>BETA VULGARIS; ASCORBIC ACID; CYSTEINE; MAGNESIUM OROTATE; MANGANESE PHOSPHATE, DIBASIC; SODIUM DIETHYL OXALACETATE; NIACINAMIDE; PULSATILLA VULGARIS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; .ALPHA.-LIPOIC ACID; .ALPHA.-KETOGLUTARIC ACID; CEROUS OXALATE NONAHYDRATE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COENZYME A; FUMARIC ACID; MALIC ACID; NADIDE; SODIUM PYRUVATE; SUCCINIC ACID; ADENOSINE TRIPHOSPHATE; BARIUM OXALOSUCCINATE; CALCIUM SULFIDE; SULFUR</SubstanceName>
    <StrengthNumber>4; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 10; 10; 10; 10</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2019-01-08</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
  </NDC>
  <NDC>
    <NDCCode>50114-1350-5</NDCCode>
    <PackageDescription>15 TABLET in 1 BOTTLE (50114-1350-5)</PackageDescription>
    <NDC11Code>50114-1350-05</NDC11Code>
    <ProductNDC>50114-1350</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Neurexan</ProprietaryName>
    <NonProprietaryName>Avena Sativa Flowering Top, Passiflora Incarnata Top, Zinc Valerate Dihydrate And Arabica Coffee Bean</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20110705</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; PASSIFLORA INCARNATA TOP; ZINC VALERATE DIHYDRATE</SubstanceName>
    <StrengthNumber>12; 2; 2; 4</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-6065-5</NDCCode>
    <PackageDescription>15 BOTTLE in 1 BOTTLE (50114-6065-5)  &gt; 100 TABLET in 1 BOTTLE (50114-6065-2)</PackageDescription>
    <NDC11Code>50114-6065-05</NDC11Code>
    <ProductNDC>50114-6065</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Engystol</ProprietaryName>
    <NonProprietaryName>Cynanchum Vincetoxicum Root And Sulfur</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20130610</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>CYNANCHUM VINCETOXICUM ROOT; SULFUR</SubstanceName>
    <StrengthNumber>6; 4</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-6150-5</NDCCode>
    <PackageDescription>15 TABLET in 1 BLISTER PACK (50114-6150-5)</PackageDescription>
    <NDC11Code>50114-6150-05</NDC11Code>
    <ProductNDC>50114-6150</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Traumeel</ProprietaryName>
    <NonProprietaryName>Aconitum Napellus, Arnica Montana Root, Atropa Belladonna, Bellis Perennis, Calendula Officinalis Flowering Top, Chamomile, Echinacea, Unspecified, Echinacea Purpurea, Hamamelis Virginiana Root Bark/stem Bark, Calcium Sulfide, Hypericum Perforatum, Mercurius Solubilis, Achillea Millefolium And Comfrey Root</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19840131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; CHAMOMILE; ECHINACEA, UNSPECIFIED; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; CALCIUM SULFIDE; HYPERICUM PERFORATUM; MERCURIUS SOLUBILIS; ACHILLEA MILLEFOLIUM; COMFREY ROOT</SubstanceName>
    <StrengthNumber>3; 3; 4; 2; 2; 3; 2; 2; 2; 8; 3; 8; 3; 8</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2017-08-08</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-6169-5</NDCCode>
    <PackageDescription>15 TABLET in 1 BOTTLE (50114-6169-5)</PackageDescription>
    <NDC11Code>50114-6169-05</NDC11Code>
    <ProductNDC>50114-6169</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Adrisin</ProprietaryName>
    <NonProprietaryName>Antimony Trisulfide, Arnica Montana Root, Arsenic Trioxide, Formic Acid, Graphite, Histamine Dihydrochloride, Strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Selenium, Sulfur, Sulfuric Acid, Tellurium And Thuja Occidentalis Leafy Twig</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20100301</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARNICA MONTANA ROOT; ARSENIC TRIOXIDE; FORMIC ACID; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; PINE TAR; SELENIUM; STRYCHNOS IGNATII SEED; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG</SubstanceName>
    <StrengthNumber>10; 8; 6; 8; 8; 10; 8; 8; 6; 10; 12; 6; 12; 22; 10; 6</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>0463-6141-05</NDCCode>
    <PackageDescription>500 TABLET in 1 BOTTLE, PLASTIC (0463-6141-05)</PackageDescription>
    <NDC11Code>00463-6141-05</NDC11Code>
    <ProductNDC>0463-6141</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Prednisone</ProprietaryName>
    <NonProprietaryName>Prednisone</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20030213</StartMarketingDate>
    <MarketingCategoryName>ANDA</MarketingCategoryName>
    <ApplicationNumber>ANDA087342</ApplicationNumber>
    <LabelerName>C.O. Truxton, Inc.</LabelerName>
    <SubstanceName>PREDNISONE</SubstanceName>
    <StrengthNumber>20</StrengthNumber>
    <StrengthUnit>mg/1</StrengthUnit>
    <Pharm_Classes>Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2019-09-21</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
    <IndicationAndUsage>Prednisone tablets and solutions are indicated in the following conditions.</IndicationAndUsage>
    <Description>Each tablet for oral administration contains. Prednisone.............................................................1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, and 50 mg. Each 5 mL of oral solution for oral administration contains. Prednisone............................................................................................................................... 5 mg. Alcohol.................................................................................................................................... 5%. Each mL of Intensol for oral administration contains. Prednisone............................................................................................................................... 5 mg. Alcohol.................................................................................................................................... 30%.</Description>
  </NDC>
  <NDC>
    <NDCCode>0641-6141-10</NDCCode>
    <PackageDescription>10 VIAL in 1 CARTON (0641-6141-10)  &gt; 10 mL in 1 VIAL (0641-6141-01)</PackageDescription>
    <NDC11Code>00641-6141-10</NDC11Code>
    <ProductNDC>0641-6141</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Neostigmine Methylsulfate</ProprietaryName>
    <NonProprietaryName>Neostigmine Methylsulfate</NonProprietaryName>
    <DosageFormName>INJECTION</DosageFormName>
    <RouteName>INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS</RouteName>
    <StartMarketingDate>19730101</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED DRUG OTHER</MarketingCategoryName>
    <LabelerName>West-ward Pharmaceutical Corp.</LabelerName>
    <SubstanceName>NEOSTIGMINE METHYLSULFATE</SubstanceName>
    <StrengthNumber>.5</StrengthNumber>
    <StrengthUnit>mg/mL</StrengthUnit>
    <Pharm_Classes>Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2017-07-11</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>54868-6141-0</NDCCode>
    <PackageDescription>30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6141-0)</PackageDescription>
    <NDC11Code>54868-6141-00</NDC11Code>
    <ProductNDC>54868-6141</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Venlafaxine Hydrochloride</ProprietaryName>
    <NonProprietaryName>Venlafaxine Hydrochloride</NonProprietaryName>
    <DosageFormName>CAPSULE, EXTENDED RELEASE</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20101108</StartMarketingDate>
    <MarketingCategoryName>ANDA</MarketingCategoryName>
    <ApplicationNumber>ANDA076565</ApplicationNumber>
    <LabelerName>Physicians Total Care, Inc.</LabelerName>
    <SubstanceName>VENLAFAXINE HYDROCHLORIDE</SubstanceName>
    <StrengthNumber>37.5</StrengthNumber>
    <StrengthUnit>mg/1</StrengthUnit>
    <Pharm_Classes>Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2018-07-24</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
    <IndicationAndUsage>Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8 and 12 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III-R or DSM-IV category of major depressive disorder (see Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The efficacy of venlafaxine hydrochloride tablets (immediate release) in the treatment of major depressive disorder in adult inpatients meeting diagnostic criteria for major depressive disorder with melancholia was established in a 4 week controlled trial (see Clinical Trials). The safety and efficacy of venlafaxine hydrochloride extended-release capsules in hospitalized depressed patients have not been adequately studied. The efficacy of venlafaxine hydrochloride extended-release capsules in maintaining a response in major depressive disorder for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial. The efficacy of venlafaxine hydrochloride tablets (immediate release) in maintaining a response in patients with recurrent major depressive disorder who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo-controlled trial (see Clinical Trials). Nevertheless, the physician who elects to use venlafaxine hydrochloride tablets/venlafaxine hydrochloride extended-release capsules for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).</IndicationAndUsage>
    <Description>Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride. The structural formula is shown below. C17H27NO2HCl M.W. 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43. Venlafaxine hydrochloride extended-release capsules are formulated as an extended-release capsule for once-a-day oral administration. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of black iron oxide, dibutyl sebacate, ethylcellulose, gelatin, polyethylene glycol, povidone, propylene glycol, shellac, sugar spheres (which contain sucrose and corn starch), sunset yellow FCF FD&amp;C yellow 6, talc, and titanium dioxide. The 37.5 mg capsules also contain D&amp;C yellow 10 and potassium hydroxide, the 75 mg capsules also contain D&amp;C yellow 10 and may contain potassium hydroxide, and the 150 mg capsules also contain potassium hydroxide.</Description>
  </NDC>
  <NDC>
    <NDCCode>54868-6141-1</NDCCode>
    <PackageDescription>90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6141-1)</PackageDescription>
    <NDC11Code>54868-6141-01</NDC11Code>
    <ProductNDC>54868-6141</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Venlafaxine Hydrochloride</ProprietaryName>
    <NonProprietaryName>Venlafaxine Hydrochloride</NonProprietaryName>
    <DosageFormName>CAPSULE, EXTENDED RELEASE</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20101108</StartMarketingDate>
    <MarketingCategoryName>ANDA</MarketingCategoryName>
    <ApplicationNumber>ANDA076565</ApplicationNumber>
    <LabelerName>Physicians Total Care, Inc.</LabelerName>
    <SubstanceName>VENLAFAXINE HYDROCHLORIDE</SubstanceName>
    <StrengthNumber>37.5</StrengthNumber>
    <StrengthUnit>mg/1</StrengthUnit>
    <Pharm_Classes>Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2018-07-24</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
    <IndicationAndUsage>Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8 and 12 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III-R or DSM-IV category of major depressive disorder (see Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The efficacy of venlafaxine hydrochloride tablets (immediate release) in the treatment of major depressive disorder in adult inpatients meeting diagnostic criteria for major depressive disorder with melancholia was established in a 4 week controlled trial (see Clinical Trials). The safety and efficacy of venlafaxine hydrochloride extended-release capsules in hospitalized depressed patients have not been adequately studied. The efficacy of venlafaxine hydrochloride extended-release capsules in maintaining a response in major depressive disorder for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial. The efficacy of venlafaxine hydrochloride tablets (immediate release) in maintaining a response in patients with recurrent major depressive disorder who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo-controlled trial (see Clinical Trials). Nevertheless, the physician who elects to use venlafaxine hydrochloride tablets/venlafaxine hydrochloride extended-release capsules for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).</IndicationAndUsage>
    <Description>Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride. The structural formula is shown below. C17H27NO2HCl M.W. 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43. Venlafaxine hydrochloride extended-release capsules are formulated as an extended-release capsule for once-a-day oral administration. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of black iron oxide, dibutyl sebacate, ethylcellulose, gelatin, polyethylene glycol, povidone, propylene glycol, shellac, sugar spheres (which contain sucrose and corn starch), sunset yellow FCF FD&amp;C yellow 6, talc, and titanium dioxide. The 37.5 mg capsules also contain D&amp;C yellow 10 and potassium hydroxide, the 75 mg capsules also contain D&amp;C yellow 10 and may contain potassium hydroxide, and the 150 mg capsules also contain potassium hydroxide.</Description>
  </NDC>
  <NDC>
    <NDCCode>54868-6141-2</NDCCode>
    <PackageDescription>180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6141-2)</PackageDescription>
    <NDC11Code>54868-6141-02</NDC11Code>
    <ProductNDC>54868-6141</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Venlafaxine Hydrochloride</ProprietaryName>
    <NonProprietaryName>Venlafaxine Hydrochloride</NonProprietaryName>
    <DosageFormName>CAPSULE, EXTENDED RELEASE</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20101108</StartMarketingDate>
    <MarketingCategoryName>ANDA</MarketingCategoryName>
    <ApplicationNumber>ANDA076565</ApplicationNumber>
    <LabelerName>Physicians Total Care, Inc.</LabelerName>
    <SubstanceName>VENLAFAXINE HYDROCHLORIDE</SubstanceName>
    <StrengthNumber>37.5</StrengthNumber>
    <StrengthUnit>mg/1</StrengthUnit>
    <Pharm_Classes>Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2018-07-24</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
    <IndicationAndUsage>Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8 and 12 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III-R or DSM-IV category of major depressive disorder (see Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The efficacy of venlafaxine hydrochloride tablets (immediate release) in the treatment of major depressive disorder in adult inpatients meeting diagnostic criteria for major depressive disorder with melancholia was established in a 4 week controlled trial (see Clinical Trials). The safety and efficacy of venlafaxine hydrochloride extended-release capsules in hospitalized depressed patients have not been adequately studied. The efficacy of venlafaxine hydrochloride extended-release capsules in maintaining a response in major depressive disorder for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial. The efficacy of venlafaxine hydrochloride tablets (immediate release) in maintaining a response in patients with recurrent major depressive disorder who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo-controlled trial (see Clinical Trials). Nevertheless, the physician who elects to use venlafaxine hydrochloride tablets/venlafaxine hydrochloride extended-release capsules for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).</IndicationAndUsage>
    <Description>Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride. The structural formula is shown below. C17H27NO2HCl M.W. 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43. Venlafaxine hydrochloride extended-release capsules are formulated as an extended-release capsule for once-a-day oral administration. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of black iron oxide, dibutyl sebacate, ethylcellulose, gelatin, polyethylene glycol, povidone, propylene glycol, shellac, sugar spheres (which contain sucrose and corn starch), sunset yellow FCF FD&amp;C yellow 6, talc, and titanium dioxide. The 37.5 mg capsules also contain D&amp;C yellow 10 and potassium hydroxide, the 75 mg capsules also contain D&amp;C yellow 10 and may contain potassium hydroxide, and the 150 mg capsules also contain potassium hydroxide.</Description>
  </NDC>
  <NDC>
    <NDCCode>50114-0113-6</NDCCode>
    <PackageDescription>10 AMPULE in 1 CARTON (50114-0113-6)  &gt; 2.2 mL in 1 AMPULE</PackageDescription>
    <NDC11Code>50114-0113-06</NDC11Code>
    <ProductNDC>50114-0113</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Echinacea Compositum Forte</ProprietaryName>
    <NonProprietaryName>Aconitum Napellus,echinacea, Unspecified, Arnica Montana Root, Baptisia Tinctoria Root ,toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Bryonia Alba Root, Eupatorium Perfoliatum Flowering Top, Euphorbia Resinifera Resin, Gelsemium Sempervirens Root, Phytolacca Americana Root, Silver Nitrate, Arsenic Trioxide, Mercuric Chloride, Phosphorus, Pulsatilla Vulgaris, Sulfur,thuja Occidentalis Leafy Twig,calcium Sulfide,lachesis Muta Venom,</NonProprietaryName>
    <DosageFormName>SOLUTION</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19930131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS; LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS PYOGENES; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC</SubstanceName>
    <StrengthNumber>5; 6; 10; 6; 8; 12; 15; 3; 8; 8; 8; 15; 12; 8; 10; 8; 10; 6; 10; 20; 20; 20; 20; 10; 10; 6; 12</StrengthNumber>
    <StrengthUnit>[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL</StrengthUnit>
    <Pharm_Classes>Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-22</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-0114-2</NDCCode>
    <PackageDescription>10 VIAL, SINGLE-DOSE in 1 CARTON (50114-0114-2)  &gt; .45 mL in 1 VIAL, SINGLE-DOSE</PackageDescription>
    <NDC11Code>50114-0114-02</NDC11Code>
    <ProductNDC>50114-0114</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Oculoheel</ProprietaryName>
    <NonProprietaryName>Cochlearia Officinalis Flowering Top,echinacea Angustifolia,euphrasia Stricta And Pilocarpus Jaborandi Leaf</NonProprietaryName>
    <DosageFormName>SOLUTION/ DROPS</DosageFormName>
    <RouteName>INTRAOCULAR</RouteName>
    <StartMarketingDate>20050627</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>COCHLEARIA OFFICINALIS FLOWERING TOP; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; PILOCARPUS JABORANDI LEAF</SubstanceName>
    <StrengthNumber>5; 5; 5; 5</StrengthNumber>
    <StrengthUnit>[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2017-01-30</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-0119-2</NDCCode>
    <PackageDescription>15 VIAL, SINGLE-DOSE in 1 CARTON (50114-0119-2)  &gt; .45 mL in 1 VIAL, SINGLE-DOSE</PackageDescription>
    <NDC11Code>50114-0119-02</NDC11Code>
    <ProductNDC>50114-0119</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Clearlife</ProprietaryName>
    <NonProprietaryName>Cochlearia Officinalis Flowering Top, Echinacea, Unspecified, Euphrasia Stricta And Pilocarpus Jaborandi Leaf</NonProprietaryName>
    <DosageFormName>SOLUTION/ DROPS</DosageFormName>
    <RouteName>OPHTHALMIC</RouteName>
    <StartMarketingDate>20130404</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>COCHLEARIA OFFICINALIS FLOWERING TOP; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; PILOCARPUS JABORANDI LEAF</SubstanceName>
    <StrengthNumber>5; 5; 5; 5</StrengthNumber>
    <StrengthUnit>[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-0227-2</NDCCode>
    <PackageDescription>30000 mg in 1 BOTTLE (50114-0227-2)</PackageDescription>
    <NDC11Code>50114-0227-02</NDC11Code>
    <ProductNDC>50114-0227</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Atropinum Compositum Rx</ProprietaryName>
    <NonProprietaryName>Atropine Sulfate And Bryonia Alba Root And Arsenic Trioxide And Berberis Vulgaris Root Bark And Citrullus Colocynthis Fruit Pulp And Cupric Acetate And Chondrodendron Tomentosum Root And Veratrum Album Root And Baptisia Tinctoria Root And Chelidonium Majus And Lytta Vesicatoria And Gonorrheal Urethral Secretion Human And Clematis Recta Flowering Top And Thuja Occidentalis Leafy Twig And Benzoic Acid And Silver Nitrate</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20030830</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ATROPINE SULFATE; BRYONIA ALBA ROOT; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; CHONDRODENDRON TOMENTOSUM ROOT; VERATRUM ALBUM ROOT; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS; LYTTA VESICATORIA; GONORRHEAL URETHRAL SECRETION HUMAN; CLEMATIS RECTA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; BENZOIC ACID; SILVER NITRATE</SubstanceName>
    <StrengthNumber>4; 1; 4; 1; 1; 2; 1; 1; 1; 1; 5; 10; 1; 1; 2; 1</StrengthNumber>
    <StrengthUnit>[hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg</StrengthUnit>
    <Pharm_Classes>Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2017-04-04</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-1122-6</NDCCode>
    <PackageDescription>10 AMPULE in 1 CARTON (50114-1122-6)  &gt; 1.1 mL in 1 AMPULE</PackageDescription>
    <NDC11Code>50114-1122-06</NDC11Code>
    <ProductNDC>50114-1122</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Vertigoheel</ProprietaryName>
    <NonProprietaryName>Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Ambergris, Kerosene</NonProprietaryName>
    <DosageFormName>SOLUTION</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19930131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; AMBERGRIS; KEROSENE</SubstanceName>
    <StrengthNumber>3; 2; 5; 7</StrengthNumber>
    <StrengthUnit>[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2017-01-30</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-1164-6</NDCCode>
    <PackageDescription>10 AMPULE in 1 CARTON (50114-1164-6)  &gt; 2.2 mL in 1 AMPULE</PackageDescription>
    <NDC11Code>50114-1164-06</NDC11Code>
    <ProductNDC>50114-1164</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Thalamus Compositum</ProprietaryName>
    <NonProprietaryName>Adenosine Cyclic Phosphate, Sus Scrofa Pineal Gland, Sus Scrofa Thalamus Lateral Geniculate Nucleus, Sus Scrofa Adrenal Gland And Viscum Album Fruiting Top</NonProprietaryName>
    <DosageFormName>SOLUTION</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19930131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; VISCUM ALBUM FRUITING TOP</SubstanceName>
    <StrengthNumber>6; 5; 8; 8; 10</StrengthNumber>
    <StrengthUnit>[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; 1/2.2mL</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-22</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-2324-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-2324-2)</PackageDescription>
    <NDC11Code>50114-2324-02</NDC11Code>
    <ProductNDC>50114-2324</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Bhi Arthritis</ProprietaryName>
    <NonProprietaryName>Antimony Potassium Tartrate, Atropa Belladonna , Blatta Orientalis, Bryonia Alba Whole, Anemone Americana, Star Anise, Ipecac, Lobelia Inflata, Naphthalene, Sodium Sulfate, Aspidosperma Quebracho-blanco Bark, And Stachys Officinalis</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20000930</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BLATTA ORIENTALIS; BRYONIA ALBA WHOLE; ANEMONE AMERICANA; STAR ANISE; IPECAC; LOBELIA INFLATA; NAPHTHALENE; SODIUM SULFATE; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; STACHYS OFFICINALIS</SubstanceName>
    <StrengthNumber>6; 6; 8; 8; 5; 6; 4; 5; 6; 6; 6; 4</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2017-04-04</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-3201-4</NDCCode>
    <PackageDescription>50 mL in 1 BOTTLE (50114-3201-4)</PackageDescription>
    <NDC11Code>50114-3201-04</NDC11Code>
    <ProductNDC>50114-3201</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Lymphomyosot Oral Drop</ProprietaryName>
    <NonProprietaryName>Araneus Diadematus, Tribasic Calcium Phosphate, Equisetum Hyemale, Ferrous Iodide, Fumaria Officinalis Flowering Top,gentiana Lutea Root, Geranium Robertianum, Levothyroxine, Myosotis Arvensis, Sodium Sulfide Nonahydrate, Nasturtium Officinale, Pinus Sylvestris Leafy Twig, Smilax Regelii Root, Scrophularia Nodosa,teucrium Scorodonia Flowering Top, And Veronica Officinalis Flowering Top</NonProprietaryName>
    <DosageFormName>LIQUID</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20071231</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; LEVOTHYROXINE; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX REGELII ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP</SubstanceName>
    <StrengthNumber>6; 4; 12; 4; 5; 4; 12; 3; 4; 4; 3; 6; 4; 3; 12; 3</StrengthNumber>
    <StrengthUnit>[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-3205-4</NDCCode>
    <PackageDescription>50 mL in 1 BOTTLE (50114-3205-4)</PackageDescription>
    <NDC11Code>50114-3205-04</NDC11Code>
    <ProductNDC>50114-3205</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Naso-heel</ProprietaryName>
    <NonProprietaryName>Goldenseal And Lobaria Pulmonaria And Potassium Dichromate And Phosphorus And Mercuric Sulfide And Ammonium Carbonate And Lemna Minor And Arum Maculatum Root And Mercuric Iodide</NonProprietaryName>
    <DosageFormName>LIQUID</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19860131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>GOLDENSEAL; LOBARIA PULMONARIA; POTASSIUM DICHROMATE; PHOSPHORUS; MERCURIC SULFIDE; AMMONIUM CARBONATE; LEMNA MINOR; ARUM MACULATUM ROOT; MERCURIC IODIDE</SubstanceName>
    <StrengthNumber>4; 4; 5; 6; 8; 3; 3; 4; 8</StrengthNumber>
    <StrengthUnit>[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2017-02-20</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-4262-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-4262-2)</PackageDescription>
    <NDC11Code>50114-4262-02</NDC11Code>
    <ProductNDC>50114-4262</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Back</ProprietaryName>
    <NonProprietaryName>Citrullus Colocynthis Fruit Pulp And Pseudognaphalium Obtusifolium And Ammonium Chloride And Gelsemium Sempervirens Root And Toxicodendron Pubescens Leaf And Arsenic Trioxide And Matricaria Recutita And</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20070830</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>CITRULLUS COLOCYNTHIS FRUIT PULP; PSEUDOGNAPHALIUM OBTUSIFOLIUM; AMMONIUM CHLORIDE; GELSEMIUM SEMPERVIRENS ROOT; TOXICODENDRON PUBESCENS LEAF; ARSENIC TRIOXIDE; MATRICARIA RECUTITA</SubstanceName>
    <StrengthNumber>5; 5; 6; 6; 8; 10; 10</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2018-04-09</LastUpdate>
    <ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
    <ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
  </NDC>
  <NDC>
    <NDCCode>50114-4263-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-4263-2)</PackageDescription>
    <NDC11Code>50114-4263-02</NDC11Code>
    <ProductNDC>50114-4263</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Bhi Back</ProprietaryName>
    <NonProprietaryName>Ammonium Chloride, Matricaria Recutita, Citrullus Colocynthis Fruit Pulp, Gelsemium Sempervirens Root, Pseudognaphalium Obtusifolium And Toxicodendron Pubescens Leaf</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20070830</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>AMMONIUM CHLORIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA RECUTITA; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF</SubstanceName>
    <StrengthNumber>6; 5; 6; 10; 8; 8</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-4290-2</NDCCode>
    <PackageDescription>30000 mg in 1 BOTTLE (50114-4290-2)</PackageDescription>
    <NDC11Code>50114-4290-02</NDC11Code>
    <ProductNDC>50114-4290</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Arthritis</ProprietaryName>
    <NonProprietaryName>Bryonia Alba Root And Toxicodendron Pubescens Leaf And Citrullus Colocynthis Fruit Pulp And Arnica Montana Root And Colchicum Autumnale Bulb And Solanum Dulcamara Top And Ledum Palustre Twig And Ranunculus Bulbosus And Berberis Vulgaris Root Bark And Causticum And Rhododendron Aureum Leaf And Lycopodium Clavatum Spore And Sulfur And Ferrosoferric Phosphate</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20000930</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; FERROSOFERRIC PHOSPHATE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RANUNCULUS BULBOSUS; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF</SubstanceName>
    <StrengthNumber>6; 8; 4; 8; 5; 6; 12; 6; 10; 6; 8; 6; 10; 4</StrengthNumber>
    <StrengthUnit>[hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-09-12</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-4291-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-4291-2)</PackageDescription>
    <NDC11Code>50114-4291-02</NDC11Code>
    <ProductNDC>50114-4291</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Bhi Arthritis</ProprietaryName>
    <NonProprietaryName>Arnica Montana Root, Berberis Vulgaris Root Bark , Bryonia Alba Root, Causticum, Citrullus Colocynthis Fruit Pulp, Solanum Dulcamara Top, Ferrosoferric Phosphate, Ledum Palustre Twig, Lycopodium Clavatum Spore, Ranunculus Bulbosus, Rhododendron Aureum Leaf,toxicodendron Pubescens Leaf And Sulfur</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20000930</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; FERROSOFERRIC PHOSPHATE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RANUNCULUS BULBOSUS; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF</SubstanceName>
    <StrengthNumber>6; 8; 4; 8; 5; 12; 6; 10; 6; 8; 6; 10; 4</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-4375-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-4375-2)</PackageDescription>
    <NDC11Code>50114-4375-02</NDC11Code>
    <ProductNDC>50114-4375</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Diarrhea</ProprietaryName>
    <NonProprietaryName>Aloe, Arsenic Trioxide, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Mercuric Chloride, Podophyllum, Potentilla Erecta Root And Veratrum Album Root</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19950131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>ACTIVATED CHARCOAL; ALOE; ARSENIC TRIOXIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; FERROSOFERRIC PHOSPHATE; MERCURIC CHLORIDE; PODOPHYLLUM; POTENTILLA ERECTA ROOT; VERATRUM ALBUM ROOT</SubstanceName>
    <StrengthNumber>12; 4; 6; 6; 6; 10; 6; 6; 4; 5</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-4376-2</NDCCode>
    <PackageDescription>100 TABLET in 1 BOTTLE (50114-4376-2)</PackageDescription>
    <NDC11Code>50114-4376-02</NDC11Code>
    <ProductNDC>50114-4376</ProductNDC>
    <ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
    <ProprietaryName>Diarrhea</ProprietaryName>
    <NonProprietaryName>Aloe, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Podophyllum, Potentilla Erecta Root And Veratrum Album Root</NonProprietaryName>
    <DosageFormName>TABLET</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>20140601</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc.</LabelerName>
    <SubstanceName>ACTIVATED CHARCOAL; ALOE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; FERROSOFERRIC PHOSPHATE; PODOPHYLLUM; POTENTILLA ERECTA ROOT; VERATRUM ALBUM ROOT</SubstanceName>
    <StrengthNumber>12; 4; 6; 6; 10; 6; 4; 5</StrengthNumber>
    <StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-29</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-5120-6</NDCCode>
    <PackageDescription>10 AMPULE in 1 CARTON (50114-5120-6)  &gt; 2.2 mL in 1 AMPULE</PackageDescription>
    <NDC11Code>50114-5120-06</NDC11Code>
    <ProductNDC>50114-5120</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Cactus Compositum</ProprietaryName>
    <NonProprietaryName>Crataegus Laevigata Fruit, Selenicereus Grandiflorus Stem, Potassium Dichromate,spigelia Anthelmia, And Nitroglycerin</NonProprietaryName>
    <DosageFormName>SOLUTION</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19930131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>CRATAEGUS LAEVIGATA FRUIT; NITROGLYCERIN; POTASSIUM DICHROMATE; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA</SubstanceName>
    <StrengthNumber>2; 5; 5; 3; 5</StrengthNumber>
    <StrengthUnit>[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL</StrengthUnit>
    <Pharm_Classes>Nitrate Vasodilator [EPC],Nitrates [Chemical/Ingredient],Vasodilation [PE]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-22</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-5206-6</NDCCode>
    <PackageDescription>10 AMPULE in 1 CARTON (50114-5206-6)  &gt; 1.1 mL in 1 AMPULE</PackageDescription>
    <NDC11Code>50114-5206-06</NDC11Code>
    <ProductNDC>50114-5206</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Galium-heel</ProprietaryName>
    <NonProprietaryName>Betula Pendula Leaf,caltha Palustris,sedum Acre,thuja Occidentalis Leafy Twig,clematis Recta Flowering Top,hedera Helix Flowering Twig, Juniper Berry, Ononis Spinosa Whole,saponaria Officinalis Root, Sempervivum Tectorum Leaf, Echinacea, Unspecified, Nitric Acid, Rancid Beef, Silver, Calcium Fluoride, Phosphorus,gold, Apis Mellifera, Galium Aparine, Galium Boreale Leaf And Urtica Urens</NonProprietaryName>
    <DosageFormName>SOLUTION</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19930131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>APIS MELLIFERA; BETULA PENDULA LEAF; CALCIUM FLUORIDE; CALTHA PALUSTRIS; CLEMATIS RECTA FLOWERING TOP; ECHINACEA, UNSPECIFIED; GALIUM APARINE; GALIUM BOREALE LEAF; GOLD; HEDERA HELIX FLOWERING TWIG; JUNIPER BERRY; NITRIC ACID; ONONIS SPINOSA WHOLE; PHOSPHORUS; RANCID BEEF; SAPONARIA OFFICINALIS ROOT; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS</SubstanceName>
    <StrengthNumber>12; 2; 8; 3; 4; 5; 3; 3; 10; 4; 4; 6; 4; 8; 6; 4; 3; 4; 8; 3; 3</StrengthNumber>
    <StrengthUnit>[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL</StrengthUnit>
    <Pharm_Classes>Non-Standardized Food Allergenic Extract [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Dietary Proteins [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Food Additives [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Bee Venoms [Chemical/Ingredient],Standardized Insect Venom Allergenic Extract [EPC]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-22</LastUpdate>
  </NDC>
  <NDC>
    <NDCCode>50114-5265-6</NDCCode>
    <PackageDescription>10 AMPULE in 1 CARTON (50114-5265-6)  &gt; 1.1 mL in 1 AMPULE</PackageDescription>
    <NDC11Code>50114-5265-06</NDC11Code>
    <ProductNDC>50114-5265</ProductNDC>
    <ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
    <ProprietaryName>Lymphomyosot</ProprietaryName>
    <NonProprietaryName>Geranium Robertianum, Nasturtium Officinale, Ferrous Iodide, Juglans Regia Leaf, Juglans Regia Fruit Rind, Immature, Myosotis Arvensis, Scrophularia Nodosa, Teucrium Scorodonia Flowering Top, Veronica Officinalis Flowering Top, Equisetum Hyemale, Fumaria Officinalis Flowering Top, Sodium Sulfate, Pinus Sylvestris Flowering Top,gentiana Lutea Root, Araneus Diadematus, Smilax Regelii Root, Tribasic Calcium Phosphate And Levothyroxine</NonProprietaryName>
    <DosageFormName>SOLUTION</DosageFormName>
    <RouteName>ORAL</RouteName>
    <StartMarketingDate>19930131</StartMarketingDate>
    <MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
    <LabelerName>Heel Inc</LabelerName>
    <SubstanceName>ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA LEAF; LEVOTHYROXINE; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS FLOWERING TOP; SCROPHULARIA NODOSA; SMILAX REGELII ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP</SubstanceName>
    <StrengthNumber>6; 4; 12; 4; 5; 4; 3; 12; 3; 4; 4; 3; 6; 4; 3; 12; 3</StrengthNumber>
    <StrengthUnit>[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL</StrengthUnit>
    <Pharm_Classes>Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient]</Pharm_Classes>
    <Status>Deprecated</Status>
    <LastUpdate>2014-08-22</LastUpdate>
  </NDC>
</NDCList>
                    

<NDCList><NDC><NDCCode>50114-6141-5</NDCCode><ProprietaryName>Coenzyme Compositum</ProprietaryName><NonProprietaryName>Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid</NonProprietaryName></NDC><NDC><NDCCode>0268-6141-06</NDCCode><ProprietaryName>Grapefruit</ProprietaryName><NonProprietaryName>Citrus X Paradisi</NonProprietaryName></NDC><NDC><NDCCode>50114-6141-2</NDCCode><ProprietaryName>Coenzyme Compositum</ProprietaryName><NonProprietaryName>Beta Vulgaris And Ascorbic Acid And Cysteine And Magnesium Orotate And Manganese Phosphate, Dibasic And Sodium Diethyl Oxalacetate And Niacinamide And Pulsatilla Vulgaris And Pyridoxine Hydrochloride And Riboflavin And Thiamine Hydrochloride And .alpha.-lipoic Acid And .alpha.-ketoglutaric Acid And Cerous Oxalate Nonahydrate And Aconitic Acid, (z)- And Anhydrous Citric Acid And Coenzyme A And Fumaric Acid And Malic Acid And Nadide And Sodium Pyruvate And Succinic Acid</NonProprietaryName></NDC><NDC><NDCCode>50114-1350-5</NDCCode><ProprietaryName>Neurexan</ProprietaryName><NonProprietaryName>Avena Sativa Flowering Top, Passiflora Incarnata Top, Zinc Valerate Dihydrate And Arabica Coffee Bean</NonProprietaryName></NDC><NDC><NDCCode>50114-6065-5</NDCCode><ProprietaryName>Engystol</ProprietaryName><NonProprietaryName>Cynanchum Vincetoxicum Root And Sulfur</NonProprietaryName></NDC><NDC><NDCCode>50114-6150-5</NDCCode><ProprietaryName>Traumeel</ProprietaryName><NonProprietaryName>Aconitum Napellus, Arnica Montana Root, Atropa Belladonna, Bellis Perennis, Calendula Officinalis Flowering Top, Chamomile, Echinacea, Unspecified, Echinacea Purpurea, Hamamelis Virginiana Root Bark/stem Bark, Calcium Sulfide, Hypericum Perforatum, Mercurius Solubilis, Achillea Millefolium And Comfrey Root</NonProprietaryName></NDC><NDC><NDCCode>50114-6169-5</NDCCode><ProprietaryName>Adrisin</ProprietaryName><NonProprietaryName>Antimony Trisulfide, Arnica Montana Root, Arsenic Trioxide, Formic Acid, Graphite, Histamine Dihydrochloride, Strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Selenium, Sulfur, Sulfuric Acid, Tellurium And Thuja Occidentalis Leafy Twig</NonProprietaryName></NDC><NDC><NDCCode>0463-6141-05</NDCCode><ProprietaryName>Prednisone</ProprietaryName><NonProprietaryName>Prednisone</NonProprietaryName></NDC><NDC><NDCCode>0641-6141-10</NDCCode><ProprietaryName>Neostigmine Methylsulfate</ProprietaryName><NonProprietaryName>Neostigmine Methylsulfate</NonProprietaryName></NDC><NDC><NDCCode>54868-6141-0</NDCCode><ProprietaryName>Venlafaxine Hydrochloride</ProprietaryName><NonProprietaryName>Venlafaxine Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>54868-6141-1</NDCCode><ProprietaryName>Venlafaxine Hydrochloride</ProprietaryName><NonProprietaryName>Venlafaxine Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>54868-6141-2</NDCCode><ProprietaryName>Venlafaxine Hydrochloride</ProprietaryName><NonProprietaryName>Venlafaxine Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>50114-0113-6</NDCCode><ProprietaryName>Echinacea Compositum Forte</ProprietaryName><NonProprietaryName>Aconitum Napellus,echinacea, Unspecified, Arnica Montana Root, Baptisia Tinctoria Root ,toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Bryonia Alba Root, Eupatorium Perfoliatum Flowering Top, Euphorbia Resinifera Resin, Gelsemium Sempervirens Root, Phytolacca Americana Root, Silver Nitrate, Arsenic Trioxide, Mercuric Chloride, Phosphorus, Pulsatilla Vulgaris, Sulfur,thuja Occidentalis Leafy Twig,calcium Sulfide,lachesis Muta Venom,</NonProprietaryName></NDC><NDC><NDCCode>50114-0114-2</NDCCode><ProprietaryName>Oculoheel</ProprietaryName><NonProprietaryName>Cochlearia Officinalis Flowering Top,echinacea Angustifolia,euphrasia Stricta And Pilocarpus Jaborandi Leaf</NonProprietaryName></NDC><NDC><NDCCode>50114-0119-2</NDCCode><ProprietaryName>Clearlife</ProprietaryName><NonProprietaryName>Cochlearia Officinalis Flowering Top, Echinacea, Unspecified, Euphrasia Stricta And Pilocarpus Jaborandi Leaf</NonProprietaryName></NDC><NDC><NDCCode>50114-0227-2</NDCCode><ProprietaryName>Atropinum Compositum Rx</ProprietaryName><NonProprietaryName>Atropine Sulfate And Bryonia Alba Root And Arsenic Trioxide And Berberis Vulgaris Root Bark And Citrullus Colocynthis Fruit Pulp And Cupric Acetate And Chondrodendron Tomentosum Root And Veratrum Album Root And Baptisia Tinctoria Root And Chelidonium Majus And Lytta Vesicatoria And Gonorrheal Urethral Secretion Human And Clematis Recta Flowering Top And Thuja Occidentalis Leafy Twig And Benzoic Acid And Silver Nitrate</NonProprietaryName></NDC><NDC><NDCCode>50114-1122-6</NDCCode><ProprietaryName>Vertigoheel</ProprietaryName><NonProprietaryName>Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Ambergris, Kerosene</NonProprietaryName></NDC><NDC><NDCCode>50114-1164-6</NDCCode><ProprietaryName>Thalamus Compositum</ProprietaryName><NonProprietaryName>Adenosine Cyclic Phosphate, Sus Scrofa Pineal Gland, Sus Scrofa Thalamus Lateral Geniculate Nucleus, Sus Scrofa Adrenal Gland And Viscum Album Fruiting Top</NonProprietaryName></NDC><NDC><NDCCode>50114-2324-2</NDCCode><ProprietaryName>Bhi Arthritis</ProprietaryName><NonProprietaryName>Antimony Potassium Tartrate, Atropa Belladonna , Blatta Orientalis, Bryonia Alba Whole, Anemone Americana, Star Anise, Ipecac, Lobelia Inflata, Naphthalene, Sodium Sulfate, Aspidosperma Quebracho-blanco Bark, And Stachys Officinalis</NonProprietaryName></NDC><NDC><NDCCode>50114-3201-4</NDCCode><ProprietaryName>Lymphomyosot Oral Drop</ProprietaryName><NonProprietaryName>Araneus Diadematus, Tribasic Calcium Phosphate, Equisetum Hyemale, Ferrous Iodide, Fumaria Officinalis Flowering Top,gentiana Lutea Root, Geranium Robertianum, Levothyroxine, Myosotis Arvensis, Sodium Sulfide Nonahydrate, Nasturtium Officinale, Pinus Sylvestris Leafy Twig, Smilax Regelii Root, Scrophularia Nodosa,teucrium Scorodonia Flowering Top, And Veronica Officinalis Flowering Top</NonProprietaryName></NDC><NDC><NDCCode>50114-3205-4</NDCCode><ProprietaryName>Naso-heel</ProprietaryName><NonProprietaryName>Goldenseal And Lobaria Pulmonaria And Potassium Dichromate And Phosphorus And Mercuric Sulfide And Ammonium Carbonate And Lemna Minor And Arum Maculatum Root And Mercuric Iodide</NonProprietaryName></NDC><NDC><NDCCode>50114-4262-2</NDCCode><ProprietaryName>Back</ProprietaryName><NonProprietaryName>Citrullus Colocynthis Fruit Pulp And Pseudognaphalium Obtusifolium And Ammonium Chloride And Gelsemium Sempervirens Root And Toxicodendron Pubescens Leaf And Arsenic Trioxide And Matricaria Recutita And</NonProprietaryName></NDC><NDC><NDCCode>50114-4263-2</NDCCode><ProprietaryName>Bhi Back</ProprietaryName><NonProprietaryName>Ammonium Chloride, Matricaria Recutita, Citrullus Colocynthis Fruit Pulp, Gelsemium Sempervirens Root, Pseudognaphalium Obtusifolium And Toxicodendron Pubescens Leaf</NonProprietaryName></NDC><NDC><NDCCode>50114-4290-2</NDCCode><ProprietaryName>Arthritis</ProprietaryName><NonProprietaryName>Bryonia Alba Root And Toxicodendron Pubescens Leaf And Citrullus Colocynthis Fruit Pulp And Arnica Montana Root And Colchicum Autumnale Bulb And Solanum Dulcamara Top And Ledum Palustre Twig And Ranunculus Bulbosus And Berberis Vulgaris Root Bark And Causticum And Rhododendron Aureum Leaf And Lycopodium Clavatum Spore And Sulfur And Ferrosoferric Phosphate</NonProprietaryName></NDC><NDC><NDCCode>50114-4291-2</NDCCode><ProprietaryName>Bhi Arthritis</ProprietaryName><NonProprietaryName>Arnica Montana Root, Berberis Vulgaris Root Bark , Bryonia Alba Root, Causticum, Citrullus Colocynthis Fruit Pulp, Solanum Dulcamara Top, Ferrosoferric Phosphate, Ledum Palustre Twig, Lycopodium Clavatum Spore, Ranunculus Bulbosus, Rhododendron Aureum Leaf,toxicodendron Pubescens Leaf And Sulfur</NonProprietaryName></NDC><NDC><NDCCode>50114-4375-2</NDCCode><ProprietaryName>Diarrhea</ProprietaryName><NonProprietaryName>Aloe, Arsenic Trioxide, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Mercuric Chloride, Podophyllum, Potentilla Erecta Root And Veratrum Album Root</NonProprietaryName></NDC><NDC><NDCCode>50114-4376-2</NDCCode><ProprietaryName>Diarrhea</ProprietaryName><NonProprietaryName>Aloe, Activated Charcoal, Citrullus Colocynthis Fruit Pulp, Cupric Acetate, Ferrosoferric Phosphate, Podophyllum, Potentilla Erecta Root And Veratrum Album Root</NonProprietaryName></NDC><NDC><NDCCode>50114-5120-6</NDCCode><ProprietaryName>Cactus Compositum</ProprietaryName><NonProprietaryName>Crataegus Laevigata Fruit, Selenicereus Grandiflorus Stem, Potassium Dichromate,spigelia Anthelmia, And Nitroglycerin</NonProprietaryName></NDC><NDC><NDCCode>50114-5206-6</NDCCode><ProprietaryName>Galium-heel</ProprietaryName><NonProprietaryName>Betula Pendula Leaf,caltha Palustris,sedum Acre,thuja Occidentalis Leafy Twig,clematis Recta Flowering Top,hedera Helix Flowering Twig, Juniper Berry, Ononis Spinosa Whole,saponaria Officinalis Root, Sempervivum Tectorum Leaf, Echinacea, Unspecified, Nitric Acid, Rancid Beef, Silver, Calcium Fluoride, Phosphorus,gold, Apis Mellifera, Galium Aparine, Galium Boreale Leaf And Urtica Urens</NonProprietaryName></NDC><NDC><NDCCode>50114-5265-6</NDCCode><ProprietaryName>Lymphomyosot</ProprietaryName><NonProprietaryName>Geranium Robertianum, Nasturtium Officinale, Ferrous Iodide, Juglans Regia Leaf, Juglans Regia Fruit Rind, Immature, Myosotis Arvensis, Scrophularia Nodosa, Teucrium Scorodonia Flowering Top, Veronica Officinalis Flowering Top, Equisetum Hyemale, Fumaria Officinalis Flowering Top, Sodium Sulfate, Pinus Sylvestris Flowering Top,gentiana Lutea Root, Araneus Diadematus, Smilax Regelii Root, Tribasic Calcium Phosphate And Levothyroxine</NonProprietaryName></NDC></NDCList>
                    

Using REST to Invoke DataLabs API

Introduction

This document is intended for developers who want to write applications that can interact with the DataLabs REST API. With DataLabs Web Services, you can create a customized services for your own website or application. You can use the REST API to retrieve DataLabs Web Services results programmatically.

Important: The REST API requires the use of an API key, which you can get from the DataLabs MyAccount Console.

Working With DataLabs REST API

You can retrieve results for a particular operation (search, getcode, etc) by sending an HTTP GET request to its URI.
For instance, the URI for a “search” request has the following format:

https://www.datalabs.health/api/{domain}/{operation}?q={query}&rt={result type}&token={token}

If the request succeeds, the server responds with a 200 OK HTTP status code and the response data.

Four parameters are required with each “search” request:

• Use the domain parameter to specify required data domain.
• Use the operation parameter to specify “format_check” operation.
• Use the q (query) parameter to specify your query.
• Use the token (API key) query parameter to identify your application.

Optional parameter:

• Use the rt (result type) parameter to specify required result type (json/xml/min.json/min.xml).

All other query parameters (if any) are optional.

Full list of API parameters:

• Use the domain parameter to specify required data domain.
• Use the operation parameter to specify “format_check” operation.
• Use the q (query) parameter to specify your query.
• Use the token (API key) query parameter to identify your application.
• Use the tin (tin number) parameter to specify your query about tin number.
• Use the tinname (tin name) parameter to specify your query about tin name.
• Use the zipcode (zip code) parameter to specify your query about zip code.
• Use the radius (radius) parameter to specify your query about radius.
• Use the fromdate (fromdate) parameter to specify your query about from date.
• Use the todate (todate) parameter to specify your query about to date.

Operations Currently Available in the DataLabs REST API

Currently DataLabs RESTful Lookup Service supports following operations:

• check_status — this method allows to get current code status.
• getcode — this method allows retrieval of full infrormation regarding one item based on the provided key.
• getcodes — this method allows retrieval of full infrormation regarding number of items based on the provided keys (q=1285636522,1730198755,1427145176,1487730636).
• search — allows retrieval of set of items based on the free-form lookup query.
• search_and_keywords — returns not only free-form lookup results but also keywords relevant to the original query.

Plus there are three NPI-specific operations:

• validate — allows to determine whether provider's information is valid based on data in the CMS database.
• paginate_with_predicates — provides server side data pagination using sorting and ordering criteria.
• search_with_predicates — this method is a "blend" of free text search and traditional prdeicate-based data selection.
• zipradius — allows to get npis by zipcode & radius.
• npideactivated — allows to get deactivated npis between two dates.

REST Search Examples

Query Parameter Reference

The query parameters you can use with the DataLabs REST API are summarized in the following table.
All parameter values need to be URL encoded.

Use Case #1 - I Need to Find Healthcare Provider (Doctor or Orgranization) Having Just Partial Information

So, you have to find healthcare provider having just partial information. For instance all you have is "EYE doctor RANIA in REDMOND". Strictly speaking, it is necessary to perform a search with minimum information and the maximum level of relevance of the result.

Coding example below demonstrates simplest implementation in C# language. By default DataLabs full text search API returns 30 results and, as you may see below, the first result in the list is "REDMOND EYE DOCTORS, PLLC" where dr. Rania Montecillo specified an owner.

Feel free to use and modify this code to find doctors you may know. If you provide more or less meaningfull information you will be pleasantly surprised to see them in the search results.

            
//--------------------------------------------------------------------------------------
// Fulltext search on NPI registry. Perform "search" operation to get most relevant results.
//--------------------------------------------------------------------------------------
using System;
using System.Net.Http;
using System.Threading.Tasks;

public class Program
{
    private const string token = "3932f3b0-cfab-11dc-95ff-0800200c9a663932f3b0-cfab-11dc-95ff-0800200c9a66";

    static async Task Main(string[] args)
    {
        string endPoint = $"https://www.datalabs.health/api/npi/search?q=EYE%20RANIA%20REDMOND&token={token}";
        using HttpClient client = new HttpClient();
        string response = await client.GetStringAsync(endPoint);

        Console.WriteLine(response);

        Console.WriteLine("Done. Press any key to exit ...");
        Console.ReadKey();
    }
}
            
        

            
{
  "NPI": [
    {
      "NPI": "1295783033",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "REDMOND EYE DOCTORS, PLLC",
      "FirstLineMailingAddress": "16375 NE 85TH ST",
      "SecondLineMailingAddress": "SUITE 102",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052-3554",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-885-7363",
      "MailingAddressFaxNumber": "425-861-5585",
      "FirstLinePracticeLocationAddress": "16375 NE 85TH ST",
      "SecondLinePracticeLocationAddress": "SUITE 102",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-3554",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-885-7363",
      "PracticeLocationAddressFaxNumber": "425-861-5585",
      "EnumerationDate": "05/04/2006",
      "LastUpdateDate": "12/11/2007",
      "AuthorizedOfficialLastName": "MONTECILLO",
      "AuthorizedOfficialFirstName": "RANIA",
      "AuthorizedOfficialTitle": "OWNER",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "O.D.",
      "AuthorizedOfficialTelephoneNumber": "425-885-7363",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "801TX",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1346319878",
      "EntityType": "Organization",
      "EIN": "N/A",
      "OrgName": "REDMOND EYE CLINIC PLLC",
      "FirstLineMailingAddress": "16150 NE 85TH ST STE 206",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052-3543",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-885-3574",
      "MailingAddressFaxNumber": "425-881-0230",
      "FirstLinePracticeLocationAddress": "16150 NE 85TH ST STE 206",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-3543",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-885-3574",
      "PracticeLocationAddressFaxNumber": "425-881-0230",
      "EnumerationDate": "11/07/2006",
      "LastUpdateDate": "07/08/2007",
      "AuthorizedOfficialLastName": "OTTEN",
      "AuthorizedOfficialFirstName": "LARRY",
      "AuthorizedOfficialMiddleName": "C",
      "AuthorizedOfficialTitle": "DR",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "O.D.",
      "AuthorizedOfficialTelephoneNumber": "425-885-3574",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "OD00001172",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization."
    },
    {
      "NPI": "1376755009",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "PERIMAN",
      "FirstName": "LAURA",
      "MiddleName": "MARIE",
      "NamePrefix": "DR.",
      "Credential": "MD",
      "FirstLineMailingAddress": "623 W HIGHLAND DR",
      "MailingAddressCityName": "SEATTLE",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98119-3446",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "206-282-2716",
      "FirstLinePracticeLocationAddress": "16150 NE 85TH ST STE 206",
      "SecondLinePracticeLocationAddress": "REDMOND EYE CLINIC",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-3543",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-885-3574",
      "EnumerationDate": "05/04/2007",
      "LastUpdateDate": "07/08/2007",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207W00000X",
      "Taxonomy1": "Ophthalmology",
      "LicenseNumber1": "MD00039796",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1659320539",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "MONTECILLO",
      "FirstName": "RANIA",
      "MiddleName": "B",
      "NamePrefix": "DR.",
      "Credential": "OD",
      "FirstLineMailingAddress": "16375 NE 85TH ST",
      "SecondLineMailingAddress": "SUITE 102",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052-3554",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-885-7363",
      "MailingAddressFaxNumber": "425-861-5585",
      "FirstLinePracticeLocationAddress": "16375 NE 85TH ST",
      "SecondLinePracticeLocationAddress": "SUITE 102",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-3554",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-885-7363",
      "PracticeLocationAddressFaxNumber": "425-861-5585",
      "EnumerationDate": "05/09/2006",
      "LastUpdateDate": "12/19/2007",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "3680",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1427560267",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "ABOU SHADI",
      "FirstName": "RANIA",
      "NamePrefix": "MRS.",
      "Credential": "RPH",
      "FirstLineMailingAddress": "8862 161ST AVENUE NE",
      "SecondLineMailingAddress": "SUITE 102",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-883-9532",
      "MailingAddressFaxNumber": "425-882-2743",
      "FirstLinePracticeLocationAddress": "8862 161ST AVENUE NE",
      "SecondLinePracticeLocationAddress": "SUITE 102",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-883-9532",
      "PracticeLocationAddressFaxNumber": "425-882-2743",
      "EnumerationDate": "11/02/2017",
      "LastUpdateDate": "11/02/2017",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "3336C0003X",
      "Taxonomy1": "Community/Retail Pharmacy",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1528050523",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "DESCHUTES EYE CLINIC PC",
      "OtherOrgName": "THE EYE SURGERY INSTITUTE",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "813 SW HIGHLAND AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-3123",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-548-7170",
      "MailingAddressFaxNumber": "541-548-3842",
      "FirstLinePracticeLocationAddress": "813 SW HIGHLAND AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-3123",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-548-7170",
      "PracticeLocationAddressFaxNumber": "541-548-3842",
      "EnumerationDate": "08/17/2005",
      "LastUpdateDate": "12/01/2010",
      "AuthorizedOfficialLastName": "TRAUSTASON",
      "AuthorizedOfficialFirstName": "OLI",
      "AuthorizedOfficialMiddleName": "I",
      "AuthorizedOfficialTitle": "PRESIDENT",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "M.D.",
      "AuthorizedOfficialTelephoneNumber": "541-548-7170",
      "TaxonomyCode1": "207W00000X",
      "Taxonomy1": "Ophthalmology",
      "PrimaryTaxonomySwitch1": "Y",
      "OtherIdentifier1": "053857000",
      "OtherIdentifierType1": "OTHER",
      "OtherIdentifierState1": "OR",
      "OtherIdentifierIssuer1": "REGENCE BCBS",
      "OtherIdentifier2": "CJ8770",
      "OtherIdentifierType2": "OTHER",
      "OtherIdentifierState2": "OR",
      "OtherIdentifierIssuer2": "RAILROAD MEDICARE",
      "OtherIdentifier3": "38080A",
      "OtherIdentifierType3": "OTHER",
      "OtherIdentifierState3": "OR",
      "OtherIdentifierIssuer3": "CLEAR CHOICE",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1477596252",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "EYE CARE SPECIALISTS NORTHWEST PLLC",
      "OtherOrgName": "THE CHILDRENS EYE DOCTORS, THE FAMILY EYE DOCTORS, WOODLAWN OPTICAL",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "17130 AVONDALE WAY NE",
      "SecondLineMailingAddress": "SUITE 111",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-885-6600",
      "MailingAddressFaxNumber": "425-885-6580",
      "FirstLinePracticeLocationAddress": "17130 AVONDALE WAY NE",
      "SecondLinePracticeLocationAddress": "SUITE 111",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-885-6600",
      "PracticeLocationAddressFaxNumber": "425-885-6580",
      "EnumerationDate": "06/13/2006",
      "LastUpdateDate": "03/03/2008",
      "AuthorizedOfficialLastName": "LENART",
      "AuthorizedOfficialFirstName": "THOMAS",
      "AuthorizedOfficialTitle": "OWNER",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "MD PHD",
      "AuthorizedOfficialTelephoneNumber": "425-885-6600",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "156FX1800X",
      "Taxonomy2": "Optician",
      "PrimaryTaxonomySwitch2": "N",
      "TaxonomyCode3": "207W00000X",
      "Taxonomy3": "Ophthalmology",
      "PrimaryTaxonomySwitch3": "Y",
      "OtherIdentifier1": "1568514032",
      "OtherIdentifierType1": "OTHER",
      "OtherIdentifierIssuer1": "NPI",
      "OtherIdentifier2": "1740297829",
      "OtherIdentifierType2": "OTHER",
      "OtherIdentifierIssuer2": "NPI",
      "OtherIdentifier3": "1205989522",
      "OtherIdentifierType3": "OTHER",
      "OtherIdentifierIssuer3": "NPI",
      "HealthcareProviderTaxonomyGroup1": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization.",
      "HealthcareProviderTaxonomyGroup2": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription2": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization.",
      "HealthcareProviderTaxonomyGroup3": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription3": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization."
    },
    {
      "NPI": "1215029343",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "EYE HEALTH PROFESSIONALS, P.C.",
      "FirstLineMailingAddress": "85 BARNES RD",
      "SecondLineMailingAddress": "SUITE 102",
      "MailingAddressCityName": "WALLINGFORD",
      "MailingAddressStateName": "CT",
      "MailingAddressPostalCode": "06492-1832",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "203-284-9448",
      "MailingAddressFaxNumber": "203-269-1361",
      "FirstLinePracticeLocationAddress": "85 BARNES RD",
      "SecondLinePracticeLocationAddress": "SUITE 102",
      "PracticeLocationAddressCityName": "WALLINGFORD",
      "PracticeLocationAddressStateName": "CT",
      "PracticeLocationAddressPostalCode": "06492-1832",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "203-284-9448",
      "PracticeLocationAddressFaxNumber": "203-269-1361",
      "EnumerationDate": "09/28/2006",
      "LastUpdateDate": "03/07/2008",
      "AuthorizedOfficialLastName": "REDMOND",
      "AuthorizedOfficialFirstName": "JOHN",
      "AuthorizedOfficialMiddleName": "W",
      "AuthorizedOfficialTitle": "PRESIDENT",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "M.D.",
      "AuthorizedOfficialTelephoneNumber": "203-284-9448",
      "TaxonomyCode1": "207W00000X",
      "Taxonomy1": "Ophthalmology",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1982789863",
      "EntityType": "Organization",
      "EIN": "N/A",
      "OrgName": "OVERLAKE EYE DESIGNS, P.C.",
      "FirstLineMailingAddress": "15230 NE 24TH ST STE Q",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052-5540",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-562-2015",
      "MailingAddressFaxNumber": "425-562-2010",
      "FirstLinePracticeLocationAddress": "15230 NE 24TH ST STE Q",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-5540",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-562-2015",
      "PracticeLocationAddressFaxNumber": "425-562-2010",
      "EnumerationDate": "10/26/2006",
      "LastUpdateDate": "07/08/2007",
      "AuthorizedOfficialLastName": "WONG",
      "AuthorizedOfficialFirstName": "TONY",
      "AuthorizedOfficialTitle": "OPTOMETRIST",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "O.D.",
      "AuthorizedOfficialTelephoneNumber": "425-562-2015",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "WA 3422 TX",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1760539969",
      "EntityType": "Organization",
      "EIN": "N/A",
      "OrgName": "DR TIFFANY J HOLLENBECK PLLC",
      "OtherOrgName": "REDMOND RIDGE EYE CARE",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "22310 NE MARKETPLACE DR",
      "SecondLineMailingAddress": "SUITE 106",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98053-2038",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-898-9222",
      "MailingAddressFaxNumber": "425-898-9225",
      "FirstLinePracticeLocationAddress": "22310 NE MARKETPLACE DR",
      "SecondLinePracticeLocationAddress": "SUITE 106",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98053-2038",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-898-9222",
      "PracticeLocationAddressFaxNumber": "425-898-9225",
      "EnumerationDate": "01/03/2007",
      "LastUpdateDate": "07/08/2007",
      "AuthorizedOfficialLastName": "HOLLENBECK",
      "AuthorizedOfficialFirstName": "TIFFANY",
      "AuthorizedOfficialMiddleName": "J",
      "AuthorizedOfficialTitle": "CO OWNER",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "O.D.",
      "AuthorizedOfficialTelephoneNumber": "425-898-9222",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "3825",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1629124649",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "TRI-COUNTY EYE CARE AND OPTOMETRY PC",
      "FirstLineMailingAddress": "3685 BURGOYNE AVE",
      "MailingAddressCityName": "HUDSON FALLS",
      "MailingAddressStateName": "NY",
      "MailingAddressPostalCode": "12839-2168",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "518-747-4100",
      "MailingAddressFaxNumber": "518-747-6151",
      "FirstLinePracticeLocationAddress": "3685 BURGOYNE AVE",
      "PracticeLocationAddressCityName": "HUDSON FALLS",
      "PracticeLocationAddressStateName": "NY",
      "PracticeLocationAddressPostalCode": "12839-2168",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "518-747-4100",
      "PracticeLocationAddressFaxNumber": "518-747-6151",
      "EnumerationDate": "01/25/2007",
      "LastUpdateDate": "08/29/2011",
      "AuthorizedOfficialLastName": "REDMOND",
      "AuthorizedOfficialFirstName": "MONICA",
      "AuthorizedOfficialTitle": "OPTOMETRIST",
      "AuthorizedOfficialCredential": "OD",
      "AuthorizedOfficialTelephoneNumber": "518-747-4100",
      "TaxonomyCode1": "152WC0802X",
      "Taxonomy1": "Corneal and Contact Management",
      "LicenseNumber1": "TUV006839-1",
      "LicenseNumberStateCode1": "NY",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "152WP0200X",
      "Taxonomy2": "Pediatrics",
      "LicenseNumber2": "TUV006839-1",
      "LicenseNumberStateCode2": "NY",
      "PrimaryTaxonomySwitch2": "Y",
      "TaxonomyCode3": "152WS0006X",
      "Taxonomy3": "Sports Vision",
      "LicenseNumber3": "TUV006839-1",
      "LicenseNumberStateCode3": "NY",
      "PrimaryTaxonomySwitch3": "N",
      "OtherIdentifier1": "10089360",
      "OtherIdentifierType1": "OTHER",
      "OtherIdentifierState1": "NY",
      "OtherIdentifierIssuer1": "CDPHP",
      "OtherIdentifier2": "C369F1",
      "OtherIdentifierType2": "OTHER",
      "OtherIdentifierState2": "NY",
      "OtherIdentifierIssuer2": "EMPIRE",
      "OtherIdentifier3": "782077",
      "OtherIdentifierType3": "OTHER",
      "OtherIdentifierState3": "NY",
      "OtherIdentifierIssuer3": "MVP",
      "OtherIdentifier4": "000408532001",
      "OtherIdentifierType4": "OTHER",
      "OtherIdentifierState4": "NY",
      "OtherIdentifierIssuer4": "BSNENY",
      "HealthcareProviderTaxonomyGroup1": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization.",
      "HealthcareProviderTaxonomyGroup2": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription2": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization.",
      "HealthcareProviderTaxonomyGroup3": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription3": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization."
    },
    {
      "NPI": "1063635506",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "DESCHUTES EYE CLINIC PC",
      "OtherOrgName": "EYE SURGERY INSTITUTE",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "813 SW HIGHLAND AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-3123",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-548-7170",
      "MailingAddressFaxNumber": "541-548-3842",
      "FirstLinePracticeLocationAddress": "813 SW HIGHLAND AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-3123",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-548-7170",
      "PracticeLocationAddressFaxNumber": "541-548-3842",
      "EnumerationDate": "04/11/2007",
      "LastUpdateDate": "12/01/2010",
      "AuthorizedOfficialLastName": "TRAUSTASON",
      "AuthorizedOfficialFirstName": "OLI",
      "AuthorizedOfficialTitle": "PRESIDENT",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "M.D.",
      "AuthorizedOfficialTelephoneNumber": "541-548-7170",
      "TaxonomyCode1": "261QA1903X",
      "Taxonomy1": "Ambulatory Surgical",
      "LicenseNumber1": "071581",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y",
      "OtherIdentifier1": "165450",
      "OtherIdentifierType1": "MEDICAID",
      "OtherIdentifierState1": "OR",
      "OtherIdentifier2": "138874101",
      "OtherIdentifierType2": "OTHER",
      "OtherIdentifierState2": "OR",
      "OtherIdentifierIssuer2": "BLUE CROSS PARTICIPATING",
      "OtherIdentifier3": "490003253",
      "OtherIdentifierType3": "OTHER",
      "OtherIdentifierState3": "OR",
      "OtherIdentifierIssuer3": "RR MEDICARE",
      "OtherIdentifier4": "180029258",
      "OtherIdentifierType4": "OTHER",
      "OtherIdentifierState4": "OR",
      "OtherIdentifierIssuer4": "UNITED HEALTHCARE RR"
    },
    {
      "NPI": "1437480456",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "VANESSA MICHEL PLLC",
      "OtherOrgName": "REDMOND RIDGE EYE CARE",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "23535 NE NOVELTY HILL RD",
      "SecondLineMailingAddress": "D302",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98053-5502",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-898-9222",
      "MailingAddressFaxNumber": "425-898-9225",
      "FirstLinePracticeLocationAddress": "23535 NE NOVELTY HILL RD",
      "SecondLinePracticeLocationAddress": "D302",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98053-5502",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-898-9222",
      "PracticeLocationAddressFaxNumber": "425-898-9225",
      "EnumerationDate": "01/15/2010",
      "LastUpdateDate": "01/17/2017",
      "AuthorizedOfficialLastName": "MICHEL",
      "AuthorizedOfficialFirstName": "VANESSA",
      "AuthorizedOfficialMiddleName": "G",
      "AuthorizedOfficialTitle": "OPTOMETRIST/OWNER",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "O.D.",
      "AuthorizedOfficialTelephoneNumber": "425-898-9222",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "3908",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1609157460",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "Y",
      "ParentOrgLBN": "OVERLAKE EYE DESIGNS, P.C.",
      "ParentOrgTIN": "N/A",
      "OrgName": "OVERLAKE EYE DESIGNS, P.C.",
      "OtherOrgName": "EYECARE AT THE COMMONS",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "15101 NE 40TH ST.",
      "SecondLineMailingAddress": "SUBMIXER / 1023 B / 1 MICROSOFT WAY",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-497-9400",
      "MailingAddressFaxNumber": "425-497-0219",
      "FirstLinePracticeLocationAddress": "15253 N.E. 40TH ST.,",
      "SecondLinePracticeLocationAddress": "BUILDING 98, S. SUBMIXER",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-497-9400",
      "PracticeLocationAddressFaxNumber": "425-497-0219",
      "EnumerationDate": "09/07/2011",
      "LastUpdateDate": "09/07/2011",
      "AuthorizedOfficialLastName": "PIAN",
      "AuthorizedOfficialFirstName": "BESSIE",
      "AuthorizedOfficialMiddleName": "M",
      "AuthorizedOfficialTitle": "SECRETARY",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "O.D.",
      "AuthorizedOfficialTelephoneNumber": "425-260-6747",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1992044903",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "ORION EYE CENTER LLC",
      "FirstLineMailingAddress": "1775 SW UMATILLA AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-7197",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-548-7170",
      "FirstLinePracticeLocationAddress": "1775 SW UMATILLA AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-7197",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-548-7170",
      "EnumerationDate": "02/11/2013",
      "LastUpdateDate": "02/11/2013",
      "AuthorizedOfficialLastName": "SCHAEFER",
      "AuthorizedOfficialFirstName": "GINGER",
      "AuthorizedOfficialTitle": "ADMINISTRATOR",
      "AuthorizedOfficialTelephoneNumber": "541-548-7170",
      "TaxonomyCode1": "207W00000X",
      "Taxonomy1": "Ophthalmology",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1265986376",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "PROLIANCE SURGEONS, INC., P.S.",
      "OtherOrgName": "PROLIANCE EASTSIDE ENT/THE CHILDREN AND FAMILY EYE DOCTORS",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "805 MADISON ST",
      "SecondLineMailingAddress": "SUITE 901",
      "MailingAddressCityName": "SEATTLE",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98104-1172",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "206-264-8100",
      "FirstLinePracticeLocationAddress": "17130 AVONDALE WAY NE",
      "SecondLinePracticeLocationAddress": "SUITE 111",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-4455",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "425-885-6600",
      "PracticeLocationAddressFaxNumber": "425-885-6580",
      "EnumerationDate": "08/05/2016",
      "LastUpdateDate": "04/21/2017",
      "AuthorizedOfficialLastName": "FITZGERALD",
      "AuthorizedOfficialFirstName": "DAVID",
      "AuthorizedOfficialMiddleName": "G.",
      "AuthorizedOfficialTitle": "CEO",
      "AuthorizedOfficialNamePrefix": "MR.",
      "AuthorizedOfficialTelephoneNumber": "206-838-2599",
      "TaxonomyCode1": "152W00000X",
      "Taxonomy1": "Optometrist",
      "LicenseNumber1": "601484763",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "207W00000X",
      "Taxonomy2": "Ophthalmology",
      "LicenseNumber2": "601484763",
      "LicenseNumberStateCode2": "WA",
      "PrimaryTaxonomySwitch2": "Y",
      "OtherIdentifier1": "222338",
      "OtherIdentifierType1": "OTHER",
      "OtherIdentifierState1": "WA",
      "OtherIdentifierIssuer1": "WA STATE L & I",
      "OtherIdentifier2": "2001403",
      "OtherIdentifierType2": "MEDICAID",
      "OtherIdentifierState2": "WA",
      "OtherIdentifier3": "G8867851",
      "OtherIdentifierType3": "OTHER",
      "OtherIdentifierState3": "WA",
      "OtherIdentifierIssuer3": "MEDICARE PTAN",
      "HealthcareProviderTaxonomyGroup1": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization.",
      "HealthcareProviderTaxonomyGroup2": "193200000X MULTI-SPECIALTY GROUP",
      "HealthcareProviderTaxonomyGroupDescription2": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization."
    },
    {
      "NPI": "1447771951",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "JEFF BINSTOCK, DVM, OD, FAAO, PLLC",
      "OtherOrgName": "REDMOND EYE CLINIC",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "16150 NE 85TH ST STE 206",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "WA",
      "MailingAddressPostalCode": "98052-3543",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "425-885-3574",
      "FirstLinePracticeLocationAddress": "16150 NE 85TH ST STE 206",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "WA",
      "PracticeLocationAddressPostalCode": "98052-3543",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "(425) 885-3574",
      "EnumerationDate": "07/05/2017",
      "LastUpdateDate": "12/27/2017",
      "AuthorizedOfficialLastName": "BINSTOCK",
      "AuthorizedOfficialFirstName": "JEFF",
      "AuthorizedOfficialTitle": "MEMBER",
      "AuthorizedOfficialNamePrefix": "DR.",
      "AuthorizedOfficialCredential": "DVM, OD, FAAO",
      "AuthorizedOfficialTelephoneNumber": "818-620-7641",
      "TaxonomyCode1": "152WC0802X",
      "Taxonomy1": "Corneal and Contact Management",
      "LicenseNumber1": "60553429",
      "LicenseNumberStateCode1": "WA",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization."
    },
    {
      "NPI": "1689189151",
      "EntityType": "Organization",
      "EIN": "N/A",
      "IsOrgSubpart": "N",
      "OrgName": "PERSONALEYES, LLC",
      "OtherOrgName": "WILLOW CREEK EYE CARE",
      "OtherOrgNameTypeCode": "3",
      "FirstLineMailingAddress": "1000 SW INDIAN AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-3039",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-548-2488",
      "MailingAddressFaxNumber": "541-548-5334",
      "FirstLinePracticeLocationAddress": "14740 NW CORNELL RD",
      "PracticeLocationAddressCityName": "PORTLAND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97229-5496",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "503-645-8002",
      "PracticeLocationAddressFaxNumber": "503-645-9455",
      "EnumerationDate": "12/06/2017",
      "LastUpdateDate": "12/06/2017",
      "AuthorizedOfficialLastName": "SHELDON",
      "AuthorizedOfficialFirstName": "TODD",
      "AuthorizedOfficialTitle": "PRESIDENT",
      "AuthorizedOfficialCredential": "OD, MBA, FAAO",
      "AuthorizedOfficialTelephoneNumber": "541-548-2488",
      "TaxonomyCode1": "261QM2500X",
      "Taxonomy1": "Medical Specialty ",
      "LicenseNumber1": "2823ATI",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1225534910",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "MAZHAR",
      "FirstName": "SAHAR",
      "MiddleName": "RANIA",
      "FirstLineMailingAddress": "1108 ROSS CLARK CIR",
      "MailingAddressCityName": "DOTHAN",
      "MailingAddressStateName": "AL",
      "MailingAddressPostalCode": "36301-3022",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "334-712-3329",
      "FirstLinePracticeLocationAddress": "1108 ROSS CLARK CIR",
      "PracticeLocationAddressCityName": "DOTHAN",
      "PracticeLocationAddressStateName": "AL",
      "PracticeLocationAddressPostalCode": "36301-3022",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "334-712-3329",
      "EnumerationDate": "04/02/2018",
      "LastUpdateDate": "04/02/2018",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "390200000X",
      "Taxonomy1": "Student in an Organized Health Care Education/Training Program",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1922502889",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "FADLALLA",
      "FirstName": "RANIA",
      "MiddleName": "ABDALLA DAW ELBEIT",
      "NamePrefix": "DR.",
      "Credential": "MD",
      "FirstLineMailingAddress": "1 BAY AVE",
      "MailingAddressCityName": "MONTCLAIR",
      "MailingAddressStateName": "NJ",
      "MailingAddressPostalCode": "07042-4837",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "973-429-6196",
      "FirstLinePracticeLocationAddress": "1 BAY AVE",
      "PracticeLocationAddressCityName": "MONTCLAIR",
      "PracticeLocationAddressStateName": "NJ",
      "PracticeLocationAddressPostalCode": "07042-4837",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "973-429-6196",
      "EnumerationDate": "03/23/2018",
      "LastUpdateDate": "03/23/2018",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "390200000X",
      "Taxonomy1": "Student in an Organized Health Care Education/Training Program",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1629068499",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "FAHOURY",
      "FirstName": "RANIA",
      "NamePrefix": "DR.",
      "Credential": "MD",
      "FirstLineMailingAddress": "4411 N HOLLAND SYLVANIA RD",
      "SecondLineMailingAddress": "SUITE 201",
      "MailingAddressCityName": "TOLEDO",
      "MailingAddressStateName": "OH",
      "MailingAddressPostalCode": "43623-3525",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "419-843-3627",
      "MailingAddressFaxNumber": "419-843-9697",
      "FirstLinePracticeLocationAddress": "4411 N HOLLAND SYLVANIA RD",
      "SecondLinePracticeLocationAddress": "SUITE 201",
      "PracticeLocationAddressCityName": "TOLEDO",
      "PracticeLocationAddressStateName": "OH",
      "PracticeLocationAddressPostalCode": "43623-3525",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "419-843-3627",
      "PracticeLocationAddressFaxNumber": "419-843-9697",
      "EnumerationDate": "10/24/2005",
      "LastUpdateDate": "09/02/2011",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207Q00000X",
      "Taxonomy1": "Family Medicine",
      "LicenseNumber1": "35086663",
      "LicenseNumberStateCode1": "OH",
      "PrimaryTaxonomySwitch1": "Y",
      "OtherIdentifier1": "2621621",
      "OtherIdentifierType1": "MEDICAID",
      "OtherIdentifierState1": "OH",
      "OtherIdentifier2": "P00401238",
      "OtherIdentifierType2": "OTHER",
      "OtherIdentifierState2": "OH",
      "OtherIdentifierIssuer2": "RAILROAD MEDICARE"
    },
    {
      "NPI": "1033186986",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "NICOLA",
      "FirstName": "RANIA",
      "MiddleName": "SOLIMAN",
      "NamePrefix": "DR.",
      "Credential": "DDS",
      "FirstLineMailingAddress": "110 S WOODLAND ST",
      "MailingAddressCityName": "WINTER GARDEN",
      "MailingAddressStateName": "FL",
      "MailingAddressPostalCode": "34787-3546",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "407-905-8827",
      "MailingAddressFaxNumber": "407-645-4587",
      "FirstLinePracticeLocationAddress": "7900 FOREST CITY RD",
      "PracticeLocationAddressCityName": "ORLANDO",
      "PracticeLocationAddressStateName": "FL",
      "PracticeLocationAddressPostalCode": "32810-3002",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "407-905-8827",
      "PracticeLocationAddressFaxNumber": "407-645-4587",
      "EnumerationDate": "02/28/2006",
      "LastUpdateDate": "07/28/2017",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "1223G0001X",
      "Taxonomy1": "General Practice",
      "LicenseNumber1": "DN15582",
      "LicenseNumberStateCode1": "FL",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "122300000X",
      "Taxonomy2": "Dentist",
      "LicenseNumber2": "DN15582",
      "LicenseNumberStateCode2": "FL",
      "PrimaryTaxonomySwitch2": "Y",
      "OtherIdentifier1": "075156100",
      "OtherIdentifierType1": "MEDICAID",
      "OtherIdentifierState1": "FL"
    },
    {
      "NPI": "1720032899",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "ALBATAINEH",
      "FirstName": "RANIA",
      "MiddleName": "QASSIEM",
      "Credential": "M.D.",
      "FirstLineMailingAddress": "11476 OKEECHOBEE BLVD",
      "MailingAddressCityName": "ROYAL PALM BEACH",
      "MailingAddressStateName": "FL",
      "MailingAddressPostalCode": "33411-8715",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "561-204-5111",
      "MailingAddressFaxNumber": "561-204-5150",
      "FirstLinePracticeLocationAddress": "11476 OKEECHOBEE BLVD",
      "PracticeLocationAddressCityName": "ROYAL PALM BEACH",
      "PracticeLocationAddressStateName": "FL",
      "PracticeLocationAddressPostalCode": "33411-8715",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "561-204-5111",
      "PracticeLocationAddressFaxNumber": "561-204-5150",
      "EnumerationDate": "05/21/2006",
      "LastUpdateDate": "09/11/2007",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207R00000X",
      "Taxonomy1": "Internal Medicine",
      "LicenseNumber1": "ME 79876",
      "LicenseNumberStateCode1": "FL",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1326095100",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "ROSBOROUGH",
      "FirstName": "RANIA",
      "MiddleName": "BAJWA",
      "Credential": "M.D.",
      "FirstLineMailingAddress": "3100 WYMAN PARK DR",
      "MailingAddressCityName": "BALTIMORE",
      "MailingAddressStateName": "MD",
      "MailingAddressPostalCode": "21211-2803",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "410-338-3500",
      "FirstLinePracticeLocationAddress": "3601 SW 160TH AVE",
      "SecondLinePracticeLocationAddress": "SUITE 250",
      "PracticeLocationAddressCityName": "MIRAMAR",
      "PracticeLocationAddressStateName": "FL",
      "PracticeLocationAddressPostalCode": "33027-6308",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "877-866-7123",
      "EnumerationDate": "05/27/2006",
      "LastUpdateDate": "12/10/2014",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207R00000X",
      "Taxonomy1": "Internal Medicine",
      "LicenseNumber1": "D0063732",
      "LicenseNumberStateCode1": "MD",
      "PrimaryTaxonomySwitch1": "Y",
      "TaxonomyCode2": "207Q00000X",
      "Taxonomy2": "Family Medicine",
      "LicenseNumber2": "0101257197",
      "LicenseNumberStateCode2": "VA",
      "PrimaryTaxonomySwitch2": "N"
    },
    {
      "NPI": "1528015310",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "HUSSEINI",
      "FirstName": "RANIA",
      "MiddleName": "I",
      "Credential": "M.D.",
      "FirstLineMailingAddress": "111 CYPRESS ST",
      "MailingAddressCityName": "BROOKLINE",
      "MailingAddressStateName": "MA",
      "MailingAddressPostalCode": "02445-6002",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "508-718-4050",
      "FirstLinePracticeLocationAddress": "20 PATRIOT PL",
      "PracticeLocationAddressCityName": "FOXBORO",
      "PracticeLocationAddressStateName": "MA",
      "PracticeLocationAddressPostalCode": "02035-1375",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "508-718-4050",
      "EnumerationDate": "05/27/2006",
      "LastUpdateDate": "04/17/2012",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207R00000X",
      "Taxonomy1": "Internal Medicine",
      "LicenseNumber1": "209649",
      "LicenseNumberStateCode1": "MA",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1760429591",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "RAYES-DANAN",
      "FirstName": "RANIA",
      "NamePrefix": "DR.",
      "Credential": "MD",
      "OtherLastName": "RAYES",
      "OtherFirstName": "RANIA",
      "OtherLastNameTypeCode": "1",
      "FirstLineMailingAddress": "2500 METROHEALTH DR",
      "MailingAddressCityName": "CLEVELAND",
      "MailingAddressStateName": "OH",
      "MailingAddressPostalCode": "44109-1900",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "216-778-7800",
      "FirstLinePracticeLocationAddress": "2500 METROHEALTH DR",
      "PracticeLocationAddressCityName": "CLEVELAND",
      "PracticeLocationAddressStateName": "OH",
      "PracticeLocationAddressPostalCode": "44109-1900",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "216-778-7800",
      "EnumerationDate": "06/01/2006",
      "LastUpdateDate": "01/30/2014",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207ZP0102X",
      "Taxonomy1": "Anatomic Pathology & Clinical Pathology",
      "LicenseNumber1": "35086346",
      "LicenseNumberStateCode1": "OH",
      "PrimaryTaxonomySwitch1": "Y",
      "OtherIdentifier1": "2687703",
      "OtherIdentifierType1": "MEDICAID",
      "OtherIdentifierState1": "OH"
    },
    {
      "NPI": "1699717660",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "AMPEY",
      "FirstName": "RANIA",
      "MiddleName": "L",
      "Credential": "LPC",
      "FirstLineMailingAddress": "5930 LOVERS LN",
      "SecondLineMailingAddress": "PREMIER NEUROPSYCHIATRY, PLC",
      "MailingAddressCityName": "PORTAGE",
      "MailingAddressStateName": "MI",
      "MailingAddressPostalCode": "49002-1673",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "269-873-1611",
      "FirstLinePracticeLocationAddress": "5930 LOVERS LN",
      "SecondLinePracticeLocationAddress": "PREMIER NEUROPSYCHIATRY, PLC",
      "PracticeLocationAddressCityName": "PORTAGE",
      "PracticeLocationAddressStateName": "MI",
      "PracticeLocationAddressPostalCode": "49002-1673",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "269-873-1611",
      "EnumerationDate": "06/12/2006",
      "LastUpdateDate": "12/30/2010",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "101YP2500X",
      "Taxonomy1": "Professional",
      "LicenseNumber1": "6401007658",
      "LicenseNumberStateCode1": "MI",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1801839667",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "ABOUJAOUDE",
      "FirstName": "RANIA",
      "Credential": "M.D.",
      "FirstLineMailingAddress": "PO BOX 1283",
      "MailingAddressCityName": "MEDFORD",
      "MailingAddressStateName": "NJ",
      "MailingAddressPostalCode": "08055-6283",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "609-677-1046",
      "MailingAddressFaxNumber": "609-677-1306",
      "FirstLinePracticeLocationAddress": "200 TRENTON RD",
      "PracticeLocationAddressCityName": "BROWNS MILLS",
      "PracticeLocationAddressStateName": "NJ",
      "PracticeLocationAddressPostalCode": "08015-1705",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "609-677-1046",
      "PracticeLocationAddressFaxNumber": "609-677-1306",
      "EnumerationDate": "06/13/2006",
      "LastUpdateDate": "09/15/2014",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207RI0200X",
      "Taxonomy1": "Infectious Disease",
      "LicenseNumber1": "39215",
      "LicenseNumberStateCode1": "KY",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "207RI0200X",
      "Taxonomy2": "Infectious Disease",
      "LicenseNumber2": "25MA07672000",
      "LicenseNumberStateCode2": "NJ",
      "PrimaryTaxonomySwitch2": "Y"
    },
    {
      "NPI": "1184645301",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "BAIK",
      "FirstName": "RANIA",
      "Credential": "D.O.",
      "FirstLineMailingAddress": "602 ROUTE 169",
      "SecondLineMailingAddress": "PO BOX 865",
      "MailingAddressCityName": "WOODSTOCK",
      "MailingAddressStateName": "CT",
      "MailingAddressPostalCode": "06281-2225",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "860-821-3406",
      "MailingAddressFaxNumber": "860-821-3407",
      "FirstLinePracticeLocationAddress": "602 ROUTE 169",
      "PracticeLocationAddressCityName": "WOODSTOCK",
      "PracticeLocationAddressStateName": "CT",
      "PracticeLocationAddressPostalCode": "06281-2225",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "860-821-3406",
      "PracticeLocationAddressFaxNumber": "860-821-3407",
      "EnumerationDate": "07/22/2006",
      "LastUpdateDate": "01/14/2016",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207Q00000X",
      "Taxonomy1": "Family Medicine",
      "LicenseNumber1": "000260",
      "LicenseNumberStateCode1": "CT",
      "PrimaryTaxonomySwitch1": "Y"
    },
    {
      "NPI": "1265443618",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "LOUTFI",
      "FirstName": "RANIA",
      "MiddleName": "H",
      "Credential": "MD",
      "FirstLineMailingAddress": "1 COOPER PLZ",
      "SecondLineMailingAddress": "THE COOPER HOSPITALIST TEAM",
      "MailingAddressCityName": "CAMDEN",
      "MailingAddressStateName": "NJ",
      "MailingAddressPostalCode": "08103-1461",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "856-342-3150",
      "MailingAddressFaxNumber": "856-968-8418",
      "FirstLinePracticeLocationAddress": "1 COOPER PLZ",
      "SecondLinePracticeLocationAddress": "THE COOPER HOSPITALIST TEAM",
      "PracticeLocationAddressCityName": "CAMDEN",
      "PracticeLocationAddressStateName": "NJ",
      "PracticeLocationAddressPostalCode": "08103-1461",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "856-342-3150",
      "PracticeLocationAddressFaxNumber": "856-968-8418",
      "EnumerationDate": "08/11/2006",
      "LastUpdateDate": "06/30/2014",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "207R00000X",
      "Taxonomy1": "Internal Medicine",
      "LicenseNumber1": "MA080819",
      "LicenseNumberStateCode1": "NJ",
      "PrimaryTaxonomySwitch1": "Y",
      "OtherIdentifier1": "01007800000",
      "OtherIdentifierType1": "OTHER",
      "OtherIdentifierIssuer1": "AMERICHOICE",
      "OtherIdentifier2": "0118460",
      "OtherIdentifierType2": "MEDICAID",
      "OtherIdentifierState2": "NJ",
      "OtherIdentifier3": "P00381177",
      "OtherIdentifierType3": "OTHER",
      "OtherIdentifierIssuer3": "RAIL ROAD MEDICARE",
      "OtherIdentifier4": "2798670000",
      "OtherIdentifierType4": "OTHER",
      "OtherIdentifierIssuer4": "AMERIHEALTH, HMO, KEYSTONE, IBC",
      "OtherIdentifier5": "1376273",
      "OtherIdentifierType5": "OTHER",
      "OtherIdentifierIssuer5": "AETNA US-HEALTHCARE",
      "OtherIdentifier6": "44132",
      "OtherIdentifierType6": "OTHER",
      "OtherIdentifierIssuer6": "UNIVERSITY HEALTH PLAN",
      "OtherIdentifier7": "60027465",
      "OtherIdentifierType7": "OTHER",
      "OtherIdentifierIssuer7": "HORIZON NJ HEALTH",
      "OtherIdentifier8": "3K6229",
      "OtherIdentifierType8": "OTHER",
      "OtherIdentifierIssuer8": "HEALTHNET",
      "OtherIdentifier9": "6761897",
      "OtherIdentifierType9": "OTHER",
      "OtherIdentifierIssuer9": "CIGNA"
    }
  ]
}

Done. Press any key to exit ...
            
        

Use Case #2 - I Need to Find Detailed Healthcare Provider Information Using Known NPI Number

This is very common scenario. You need to get full replica of NPI record. Again, it simple. Just use code provided below. API response may contain single NPI record, or empty list in case NPI does not exist in the CMS National Plan and Provider Enumeration System (NPPES) Registry.

                
    //--------------------------------------------------------------------------------------
    // Perform "getcode" operation to get healthcare provider information using NPI number.
    //--------------------------------------------------------------------------------------
    using System;
    using System.Net.Http;
    using System.Threading.Tasks;

    public class Program
    {
        private const string token = "3932f3b0-cfab-11dc-95ff-0800200c9a663932f3b0-cfab-11dc-95ff-0800200c9a66";

        static async Task Main(string[] args)
        {
            string endPoint = $"https://www.datalabs.health/api/npi/getcode?q=1285636522&token={token}";
            using HttpClient client = new HttpClient();
            string response = await client.GetStringAsync(endPoint);

            Console.WriteLine(response);

            Console.WriteLine("Done. Press any key to exit ...");
            Console.ReadKey();
        }
    }
                
            

                
    {
      "NPI": [
        {
          "NPI": "1285636522",
          "EntityType": "Organization",
          "EIN": "N/A",
          "IsOrgSubpart": "N",
          "OrgName": "MEDSTAR GEORGETOWN MEDICAL CENTER, INC",
          "FirstLineMailingAddress": "PO BOX 418283",
          "MailingAddressCityName": "BOSTON",
          "MailingAddressStateName": "MA",
          "MailingAddressPostalCode": "02241-8283",
          "MailingAddressCountryCode": "US",
          "FirstLinePracticeLocationAddress": "3800 RESERVOIR RD NW",
          "PracticeLocationAddressCityName": "WASHINGTON",
          "PracticeLocationAddressStateName": "DC",
          "PracticeLocationAddressPostalCode": "20007-2113",
          "PracticeLocationAddressCountryCode": "US",
          "PracticeLocationAddressTelephoneNumber": "888-896-1400",
          "EnumerationDate": "06/01/2005",
          "LastUpdateDate": "11/25/2011",
          "AuthorizedOfficialLastName": "SCHNEIDER",
          "AuthorizedOfficialFirstName": "STEPHANIE",
          "AuthorizedOfficialTitle": "VP",
          "AuthorizedOfficialTelephoneNumber": "703-558-1403",
          "TaxonomyCode1": "207R00000X",
          "Taxonomy1": "Internal Medicine",
          "LicenseNumber1": "=========",
          "LicenseNumberStateCode1": "DC",
          "PrimaryTaxonomySwitch1": "Y",
          "OtherIdentifier1": "W677",
          "OtherIdentifierType1": "OTHER",
          "OtherIdentifierState1": "DC",
          "OtherIdentifierIssuer1": "BLUE SHIELD ADULT PCP GRP",
          "OtherIdentifier2": "027174100",
          "OtherIdentifierType2": "MEDICAID",
          "OtherIdentifierState2": "DC",
          "OtherIdentifier3": "097005100",
          "OtherIdentifierType3": "MEDICAID",
          "OtherIdentifierState3": "MD",
          "OtherIdentifier4": "442AGE",
          "OtherIdentifierType4": "OTHER",
          "OtherIdentifierState4": "MD",
          "OtherIdentifierIssuer4": "BLUE SHIELD PEDS PCP GRP#",
          "OtherIdentifier5": "6572",
          "OtherIdentifierType5": "OTHER",
          "OtherIdentifierState5": "DC",
          "OtherIdentifierIssuer5": "BLUE SHIELD GROUP NUMBER",
          "OtherIdentifier6": "W675",
          "OtherIdentifierType6": "OTHER",
          "OtherIdentifierState6": "DC",
          "OtherIdentifierIssuer6": "BLUE SHIELD PEDS PCP GRP#",
          "HealthcareProviderTaxonomyGroup1": "193200000X MULTI-SPECIALTY GROUP",
          "HealthcareProviderTaxonomyGroupDescription1": "Multi-Specialty Group - A business group of one or more individual practitioners, who practice with different areas of specialization."
        }
      ]
    }
    Done. Press any key to exit ...
                
            

Use Case #3 - I Need to Get Multiple Healthcare Providers Using List of NPI Numbers

You may need to perform bulk search for performance optimization. The "getcodes" operation allows you to decrease number of round trips in orders of magnitude. For instance you can get information about hundred NPI in one REST call, instead of sending NPI numbers one-by-one.

                
    //--------------------------------------------------------------------------------------
    // Perform "getcodes" operation to get multiple healthcare providers using list of NPIs. 
    //--------------------------------------------------------------------------------------
    using System;
    using System.Net.Http;
    using System.Threading.Tasks;

    public class Program
    {
        private const string token = "3932f3b0-cfab-11dc-95ff-0800200c9a663932f3b0-cfab-11dc-95ff-0800200c9a66";

        static async Task Main(string[] args)
        {
            string endPoint = $"https://www.datalabs.health/api/npi/getcodes?q=1285636522,1730198755,1427145176&rt=minjson&token={token}";
            using HttpClient client = new HttpClient();
            string response = await client.GetStringAsync(endPoint);

            Console.WriteLine(response);

            Console.WriteLine("Done. Press any key to exit ...");
            Console.ReadKey();
        }
    }
                
            

                
    {
      "NPI": [
        {
          "NPI": "1285636522",
          "OrgName": "MEDSTAR GEORGETOWN MEDICAL CENTER, INC",
          "FirstLinePracticeLocationAddress": "3800 RESERVOIR RD NW",
          "PracticeLocationAddressCityName": "WASHINGTON",
          "PracticeLocationAddressStateName": "DC",
          "PracticeLocationAddressPostalCode": "20007-2113",
          "PracticeLocationAddressCountryCode": "US",
          "PracticeLocationAddressTelephoneNumber": "888-896-1400"
        },
        {
          "NPI": "1730198755",
          "OrgName": "MEDSTAR GEORGETOWN MEDICAL CENTER",
          "FirstLinePracticeLocationAddress": "3800 RESERVOIR RD NW",
          "PracticeLocationAddressCityName": "WASHINGTON",
          "PracticeLocationAddressStateName": "DC",
          "PracticeLocationAddressPostalCode": "20007-2113",
          "PracticeLocationAddressCountryCode": "US",
          "PracticeLocationAddressTelephoneNumber": "888-896-1400"
        },
        {
          "NPI": "1427145176",
          "OrgName": "MEDSTAR - GEORGETOWN MEDICAL CENTER, INC.",
          "OtherOrgName": "GEORGETOWN UNIVERSITY HOSPITAL",
          "OtherOrgNameTypeCode": "3",
          "FirstLinePracticeLocationAddress": "3800 RESERVOIR RD., NW",
          "PracticeLocationAddressCityName": "WASHINGTON",
          "PracticeLocationAddressStateName": "DC",
          "PracticeLocationAddressPostalCode": "20007-2113",
          "PracticeLocationAddressCountryCode": "US",
          "PracticeLocationAddressTelephoneNumber": "202-444-3000",
          "PracticeLocationAddressFaxNumber": "202-444-3095"
        }
      ]
    }
    Done. Press any key to exit ...
                
            

Use Case #4 - I Need to Check NPI Number Status

Again, very common scenario. You just need to check NPI number status. It is simple. Take a look at the code below. Expected result contains requested NPI number, status, and short status description.

                
    //--------------------------------------------------------------------------------------
    // Perform "check_status" operation to get NPI Number status (active, deactivated, etc).
    //--------------------------------------------------------------------------------------
    using System;
    using System.Net.Http;
    using System.Threading.Tasks;

    public class Program
    {
        private const string token = "3932f3b0-cfab-11dc-95ff-0800200c9a663932f3b0-cfab-11dc-95ff-0800200c9a66";

        static async Task Main(string[] args)
        {
            string endPoint = $"https://www.datalabs.health/api/npi/check_status?q=1285636522&token={token}";
            using HttpClient client = new HttpClient();
            string response = await client.GetStringAsync(endPoint);

            Console.WriteLine(response);

            Console.WriteLine("Done. Press any key to exit ...");
            Console.ReadKey();
        }
    }
                
            

                
    {
      "Code": "1285636522",
      "Status": "Active",
      "Message": "\"1285636522\" NPI Number does exist and has \"active\" status"
    }
                
    Done. Press any key to exit ...
                
            

Use Case #5 - I need to retrieve a list of healthcare providers based on specified search parameters.

The system allows users to retrieve a list of healthcare providers by filtering on specified fields (e.g., organization name, state, city, ZIP code, etc.). The example below demonstrates how to retrieve all providers with a specified city, state, and ZIP code.

                
    //--------------------------------------------------------------------------------------
    // Perform "search_with_predicates" operation to get multiple healthcare providers using specified city, state, and ZIP code. 
    //--------------------------------------------------------------------------------------
    using System;
    using System.Net.Http;
    using System.Threading.Tasks;

    public class Program
    {
        private const string token = "3932f3b0-cfab-11dc-95ff-0800200c9a663932f3b0-cfab-11dc-95ff-0800200c9a66";

        static async Task Main(string[] args)
        {
            string endPoint = $"https://www.datalabs.health/api/npi/search_with_predicates?q=&qf=City:true:REDMOND&qf=State:true:OR&qf=Zip:true:97756-9069&rt=json&token={token}";
            using HttpClient client = new HttpClient();
            string response = await client.GetStringAsync(endPoint);

            Console.WriteLine(response);

            Console.WriteLine("Done. Press any key to exit ...");
            Console.ReadKey();
        }
    }
                
            

                
{
  "NPI": [
    {
      "NPI": "1083349906",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "STAFFORD",
      "FirstName": "KADY",
      "NamePrefix": "MS.",
      "Credential": "LPC",
      "FirstLineMailingAddress": "13574 SW HIGHWAY 126",
      "MailingAddressCityName": "POWELL BUTTE",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97753-1541",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-480-6360",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-203-0307",
      "EnumerationDate": "07/24/2022",
      "LastUpdateDate": "04/21/2025",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "101YP2500X",
      "Taxonomy1": "Professional Counselor",
      "LicenseNumber1": "LPC6225",
      "LicenseNumberStateCode1": "ID",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "101YP2500X",
      "Taxonomy2": "Professional Counselor",
      "LicenseNumber2": "C9084",
      "LicenseNumberStateCode2": "OR",
      "PrimaryTaxonomySwitch2": "Y",
      "CertificationDate": "04/21/2025",
      "PrimaryTaxonomyCode": "101YP2500X",
      "PrimaryTaxonomy": "Professional Counselor"
    },
    {
      "NPI": "1215724679",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "SCHAY",
      "FirstName": "ANGELICA",
      "MiddleName": "NICOLE",
      "FirstLineMailingAddress": "6396 SW MCVEY AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-9069",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-389-1841",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1841",
      "EnumerationDate": "04/21/2025",
      "LastUpdateDate": "04/21/2025",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "101Y00000X",
      "Taxonomy1": "Counselor",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "04/21/2025",
      "PrimaryTaxonomyCode": "101Y00000X",
      "PrimaryTaxonomy": "Counselor"
    },
    {
      "NPI": "1013556505",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "IVENS",
      "FirstName": "KRYSTA",
      "FirstLineMailingAddress": "743 NW QUINCE AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-1250",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "360-526-1448",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "971-217-6150",
      "EnumerationDate": "12/31/2019",
      "LastUpdateDate": "02/15/2025",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "101YM0800X",
      "Taxonomy1": "Mental Health Counselor",
      "PrimaryTaxonomySwitch1": "N",
      "TaxonomyCode2": "101YP2500X",
      "Taxonomy2": "Professional Counselor",
      "LicenseNumber2": "C7963",
      "LicenseNumberStateCode2": "OR",
      "PrimaryTaxonomySwitch2": "Y",
      "CertificationDate": "02/15/2025",
      "PrimaryTaxonomyCode": "101YP2500X",
      "PrimaryTaxonomy": "Professional Counselor"
    },
    {
      "NPI": "1497336275",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "ARANT",
      "FirstName": "ERIN",
      "MiddleName": "HENNESSEY",
      "FirstLineMailingAddress": "4639 SW 37TH ST",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-6776",
      "MailingAddressCountryCode": "US",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1848",
      "EnumerationDate": "04/14/2021",
      "LastUpdateDate": "04/14/2021",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "225X00000X",
      "Taxonomy1": "Occupational Therapist",
      "LicenseNumber1": "390047",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "04/14/2021",
      "PrimaryTaxonomyCode": "225X00000X",
      "PrimaryTaxonomy": "Occupational Therapist"
    },
    {
      "NPI": "1174191407",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "GRIMALT",
      "FirstName": "EUGENIA",
      "MiddleName": "N",
      "Credential": "PT",
      "FirstLineMailingAddress": "6396 SW MCVEY AVE",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-9069",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-389-1848",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1848",
      "EnumerationDate": "06/14/2021",
      "LastUpdateDate": "06/14/2021",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "2251P0200X",
      "Taxonomy1": "Pediatric Physical Therapist",
      "LicenseNumber1": "63979",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y",
      "HealthcareProviderTaxonomyGroup1": "193400000X SINGLE SPECIALTY  GROUP",
      "HealthcareProviderTaxonomyGroupDescription1": "Single Specialty Group - A business group of one or more individual practitioners, all of who practice with the same area of specialization.",
      "CertificationDate": "06/14/2021",
      "PrimaryTaxonomyCode": "2251P0200X",
      "PrimaryTaxonomy": "Pediatric Physical Therapist"
    },
    {
      "NPI": "1912604117",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "PAINTER",
      "FirstName": "JENNIFER",
      "FirstLineMailingAddress": "20080 DOANNA WAY UNIT 3",
      "MailingAddressCityName": "BEND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97702-2931",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "209-743-9813",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1848",
      "EnumerationDate": "02/08/2023",
      "LastUpdateDate": "02/08/2023",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "101YM0800X",
      "Taxonomy1": "Mental Health Counselor",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "02/08/2023",
      "PrimaryTaxonomyCode": "101YM0800X",
      "PrimaryTaxonomy": "Mental Health Counselor"
    },
    {
      "NPI": "1396434700",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "GROVE",
      "FirstName": "JENNIFER",
      "MiddleName": "RHEA",
      "FirstLineMailingAddress": "303 NW BROADWAY ST",
      "MailingAddressCityName": "BEND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97703-2658",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "801-573-6047",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "801-573-6047",
      "EnumerationDate": "05/02/2023",
      "LastUpdateDate": "05/02/2023",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "1041C0700X",
      "Taxonomy1": "Clinical Social Worker",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "05/02/2023",
      "PrimaryTaxonomyCode": "1041C0700X",
      "PrimaryTaxonomy": "Clinical Social Worker"
    },
    {
      "NPI": "1407698970",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "REDDEN",
      "FirstName": "SHANNON",
      "Credential": "CHW",
      "OtherLastName": "MCDOUGALL",
      "OtherFirstName": "SHANNON",
      "OtherLastNameTypeCode": "1",
      "FirstLineMailingAddress": "2312 NE 5TH ST",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-8488",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-460-2192",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1848",
      "PracticeLocationAddressFaxNumber": "541-550-7956",
      "EnumerationDate": "06/06/2024",
      "LastUpdateDate": "06/06/2024",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "172V00000X",
      "Taxonomy1": "Community Health Worker",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "06/06/2024",
      "PrimaryTaxonomyCode": "172V00000X",
      "PrimaryTaxonomy": "Community Health Worker"
    },
    {
      "NPI": "1942022256",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "JACQUOT",
      "FirstName": "SHAYLA",
      "FirstLineMailingAddress": "PO BOX 1397",
      "MailingAddressCityName": "BEND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97709-1397",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-389-1848",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1848",
      "EnumerationDate": "10/28/2024",
      "LastUpdateDate": "10/28/2024",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "101YM0800X",
      "Taxonomy1": "Mental Health Counselor",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "10/26/2024",
      "PrimaryTaxonomyCode": "101YM0800X",
      "PrimaryTaxonomy": "Mental Health Counselor"
    },
    {
      "NPI": "1912723131",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "WEIMER",
      "FirstName": "ALAYNA",
      "FirstLineMailingAddress": "2748 NW 19TH ST",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-7766",
      "MailingAddressCountryCode": "US",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-499-8292",
      "EnumerationDate": "12/03/2024",
      "LastUpdateDate": "12/03/2024",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "171M00000X",
      "Taxonomy1": "Case Manager/Care Coordinator",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "12/03/2024",
      "PrimaryTaxonomyCode": "171M00000X",
      "PrimaryTaxonomy": "Case Manager/Care Coordinator"
    },
    {
      "NPI": "1790594125",
      "EntityType": "Individual",
      "IsSoleProprietor": "Y",
      "LastName": "WIDDER",
      "FirstName": "JENNIFER",
      "MiddleName": "LYNN",
      "FirstLineMailingAddress": "22350 CALGARY DR",
      "MailingAddressCityName": "BEND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97702-9216",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "541-749-8895",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1858",
      "EnumerationDate": "12/31/2024",
      "LastUpdateDate": "12/31/2024",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "175T00000X",
      "Taxonomy1": "Peer Specialist",
      "LicenseNumber1": "112910",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "12/31/2024",
      "PrimaryTaxonomyCode": "175T00000X",
      "PrimaryTaxonomy": "Peer Specialist"
    },
    {
      "NPI": "1538965306",
      "EntityType": "Individual",
      "IsSoleProprietor": "N",
      "LastName": "PARSONS",
      "FirstName": "JEANINE",
      "MiddleName": "JEWELL",
      "FirstLineMailingAddress": "2821 SW 28TH ST",
      "MailingAddressCityName": "REDMOND",
      "MailingAddressStateName": "OR",
      "MailingAddressPostalCode": "97756-8681",
      "MailingAddressCountryCode": "US",
      "MailingAddressTelephoneNumber": "760-927-4761",
      "FirstLinePracticeLocationAddress": "6396 SW MCVEY AVE",
      "PracticeLocationAddressCityName": "REDMOND",
      "PracticeLocationAddressStateName": "OR",
      "PracticeLocationAddressPostalCode": "97756-9069",
      "PracticeLocationAddressCountryCode": "US",
      "PracticeLocationAddressTelephoneNumber": "541-389-1848",
      "EnumerationDate": "02/21/2025",
      "LastUpdateDate": "02/21/2025",
      "GenderCode": "F",
      "Gender": "Female",
      "TaxonomyCode1": "175T00000X",
      "Taxonomy1": "Peer Specialist",
      "LicenseNumber1": "113398",
      "LicenseNumberStateCode1": "OR",
      "PrimaryTaxonomySwitch1": "Y",
      "CertificationDate": "02/21/2025",
      "PrimaryTaxonomyCode": "175T00000X",
      "PrimaryTaxonomy": "Peer Specialist"
    }
  ]
}
Done. Press any key to exit ...